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Abstract 
 
This is a pilot study to investigate the relationship between disease gene status and 
the structure of the human genome with specific reference to regions of 
recombination. It compares certain characteristics of a control set of genes, with 
no reported association or function in any known disease, with a second set of 
well-curated genes with a known association to a disease.  
One of the benefits of recombination is the introduction of new combinations of 
genetic variation in the genome. Recombination hotspots are regions on the 
chromosome where higher than normal frequencies of breaking and rejoining 
between homologous chromosomes occur during meiosis. The hotspot regions 
exhibit both a non-random distribution across the human genome and varying 
frequencies of breaking and rejoining.  
The study analyzed a set of features that represent general properties of human 
genes; namely base composition (percentage GC content), genetic variation 
(single nucleotide polymorphisms - SNPs), gene length, and positional effect 
(distance from chromosome end), in both the disease-associated gene set and the 
control set. These features were linked to recombination hotspots in the human 
genome and the frequency of recombination at these hotspots. Descriptive 
statistics was used to determine differences between the occurrences of these 
features in disease-associated genes compared to the control set, as well as 
differences in the occurrence of these same features in subset of genes containing 
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an internal recombination hotspot compared to the genes with no internal 
recombination hotspot. 
The study found that disease-associated genes are generally longer than those in 
the control set, which is consistent with previous studies. It also found that 
disease-associated genes are much more likely to contain a recombination hotspot 
than those genes with no disease association. The study did not, however, find any 
association between disease gene status and the other set of features; namely GC 
content, SNP numbers or the position of a gene on the chromosome. Further 
analysis of the data suggested that the increased probability of disease-associated 
genes containing a recombination hotspot is most likely an effect of longer gene 
length and that the presence of a recombination hotspot is not sufficient in its own 
right to cause disease gene status. 
May 2012 
 
 
 
 
 
 
 
 
 
 
 
 vi 
 
Declaration 
 
I declare that A computational characterisation of the relationship between 
genome structure and disease genes is my own work, that it has not been 
submitted for any degree or examination in any other university, and that all the 
sources I have used or quoted have been indicated and acknowledged by complete 
references.  
 
Tracey D. Kibler       May 2012 
 
 
Signed: __________________________ 
 
 
 
 
 
 
 
 
 
 
 vii 
 
Acknowledgements 
 
I would like to express my gratitude to all those who made it possible to complete 
this thesis. I want to thank the South African National Bioinformatics Institute 
(SANBI) for allowing me the opportunity to complete my masters’ degree with 
them.   
I am deeply indebted to my supervisor Dr Nicki Tiffin whose help, suggestions 
and encouragement helped me in all areas of my research and in writing, not only 
the thesis, but also with the Python scripts. Thank you, also, to my co-supervisor 
Prof. Alan Christoffels. 
I would like to thank Galen Wright for his careful review of this thesis and Sumir 
Panji and Darlington Mapiye for their advice and assistance with the technical 
sections. To all my other colleagues and friends at SANBI, thank you for your 
support and encouragement.  
Mostly, I would like to give my special thank you to my husband Rolf van Zyl 
whose patience, support and love enabled me to complete this work. He presented 
me with the opportunity to do this and without his continued support and 
encouragement I would have been lost.  
 
 
 
 
 
 
 viii 
 
Index 
 
Title Page................................................................................................................. i 
Keywords ............................................................................................................... ii 
Abbreviations ....................................................................................................... iii 
Abstract ................................................................................................................. iv 
Declaration ............................................................................................................ vi 
Acknowledgements .............................................................................................. vii 
Index .................................................................................................................... viii 
Table of contents .................................................................................................. ix 
List of Tables ...................................................................................................... xiv 
Table of Figures .................................................................................................... xv 
 
 
 
 
 
 
 
 
 
 ix 
 
Table of Contents 
 
CHAPTER ONE 
Background and Introduction ................................................................................... 1 
1.1. The Process and Mechanisms of Homologous Recombination .............. 4 
1.1.1.  Meiosis and Crossing over  ........................................................... 5 
1.1.2.  The Holliday Junction ................................................................... 7 
1.1.3.  The CentiMorgan .......................................................................... 9 
1.1.4.  Gene Mapping ............................................................................. 11 
1.1.5.  Haploblock Structure .................................................................. 14 
1.1.6.  Linkage Disequilibrium............................................................... 14 
1.2.  Characterising Recombination Hotspots ............................................... 16 
1.2.1.  The International HapMap Project  ............................................. 16 
1.3.  Current Protocols for Estimating Recombination Rates ....................... 18 
1.4.  Defining a Gene and Gene Features ...................................................... 19 
1.4.1. Base composition: percentage GC content.................................. 24 
1.4.2. Genetic variation: Single Nucleotide Polymorphisms (SNPs) .... 24 
1.4.3. Gene length ................................................................................. 30 
1.4.4 Position Effect: Distance from chromosome end ........................ 33 
 
 
 
 
 
 x 
 
 Table of Contents (cont..) 
 
1.5. Data Sources .......................................................................................... 36 
1.5.1. Online Mendelian Inheritance in Man  ....................................... 36 
1.5.2 The Ensembl Project ................................................................... 37 
1.6.  Rationale for current study .................................................................... 39 
CHAPTER TWO 
Materials and Methods  .......................................................................................... 43 
2.1. Developing the Scoring System  .............................................................. 45 
2.2. Compilation of Test Sets and Recombination Hotspot Assembly  ......... 48 
2.3. Collecting Gene Characteristic Data  ...................................................... 52 
2.3.1.  Determining Base Composition: GC content  .............................. 52 
2.3.2.  Calculating Genetic Variation: SNP count .................................. 52 
2.3.3. Establishing Gene Length ............................................................ 53 
2.3.4. Mapping Position Effect: Distance from chromosome end  ........ 53 
2.4. Data Analysis ........................................................................................... 55 
2.5. Software  .................................................................................................. 58 
 
 
 
 
 
 
 xi 
 
 Table of Contents (cont..) 
CHAPTER THREE 
Results  ................................................................................................................... 59 
3.1. Are there any major differences in the characteristics of disease-
associated genes compared to the genes in the control set?  ................. 60 
3.1.1.  Analysis of Base Composition: GC content ................................ 60 
3.1.2.  Analysis of Genetic Variation: SNP count .................................. 62 
3.1.3.  Analysis of Gene Length  ............................................................. 64 
3.1.4.  Analysis of Position Effect: Distance from chromosome end  .... 66 
3.2. Are there considerable differences in the characteristics of genes 
containing internal hotspots compared to genes with no internal 
hotspots?    ............................................................................................. 68 
3.2.1.  Analysis of Base Composition: GC content ................................ 68 
3.2.2.  Analysis of Genetic Variation: SNP count .................................. 70 
3.2.3.  Analysis of Gene Length  ............................................................. 72 
3.2.4.  Analysis of Position Effect: Distance from chromosome end  .... 74 
3.3.  Is there variation in the frequency of recombination in the hotspots of 
disease-associated genes compared to the frequency of recombination in 
the hotspots of the genes in the control set?  ......................................... 76 
 
 
 
 
 xii 
 
 Table of Contents (cont..) 
 
3.3.1.  Analysis of the occurrence of recombination hotspots in disease-
associated genes compared to recombination hotspots of the genes 
in the control set  .......................................................................... 76 
3.3.2.  Analysis of the frequency of recombination in the hotspots of 
disease-associated genes compared to the frequency of 
recombination in the hotspots of the genes in the control set  ..... 78 
3.3.3.  Analysis of the frequency of recombination of the highest scoring 
hotspot for each disease-associated gene compared to the 
frequency of recombination of the highest scoring hotspot of each 
gene in the control set  ................................................................. 80 
3.3.4.  Analysis of the frequency, distance and overall scoring metric of 
hotspots nearest to disease-associated genes compared to the 
frequency, distance and overall scoring metric of hotspots nearest 
to the genes in the control set  ...................................................... 82 
CHAPTER FOUR 
Discussion and Conclusion .................................................................................... 84 
Future Directions .................................................................................................... 97 
 
 
 
 
 
 xiii 
 
 Table of Contents (cont..) 
 
REFERENCES ..................................................................................................... 99 
ELECTRONIC REFERENCES ....................................................................... 113 
APPENDIX ......................................................................................................... 115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv 
 
List of Tables 
 
Table 1   Gene Feature Directory ...................................................................... 23 
Table 2 Functional effects of SNPs. ................................................................ 29 
Table 3  Previously reported data of gene and protein length .......................... 32 
Table 4 Tabulated displays of the mean and measure of standard deviation 
(S.D) for the reviewed features of the 13095 disease genes and 38256 
non-disease genes ............................................................................... 86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xv 
 
Table of Figures 
 
Figure 1  The stages of Meiosis – An Overview .................................................. 6 
Figure 2 Holliday model of recombination ......................................................... 8 
Figure 3 Illustration of the CentiMorgan .......................................................... 10 
Figure 4 Comparison of a Genetic map and Physical map ............................... 13 
Figure 5 Linkage Disequilibrium ...................................................................... 15 
Figure 6  Illustration of the Human gene ........................................................... 22 
Figure 7 Single Nucleotide Polymorphisms (SNPs) ......................................... 27 
Figure 8  SNP number per chromosome  ........................................................... 31 
Figure 9  Gene Distribution per chromosome .................................................... 35 
Figure 10 Overview of methods applied to compilation of test sets and assembly 
of recombination hotspot data ............................................................. 44 
Figure 11 Graphical Illustration of Scoring System Metric ................................ 47 
Figure 12 Boxplot - Display of Distribution ...................................................... 56 
Figure 13 Percentage GC content in disease-associated genes compared to the 
genes in the control set ....................................................................... 61 
 
 
 
 
 xvi 
 
Table of Figures (cont..) 
 
Figure 14 SNP density in disease-associated genes compared to the genes in the 
control set ........................................................................................... 63 
Figure 15 Length of disease-associated genes compared to the genes in the 
control set  .......................................................................................... 65 
Figure 16 Position of genes on chromosome ...................................................... 67 
Figure 17 Percentage GC content in genes with an internal hotspot compared to 
genes with no internal hotspot ............................................................ 69 
Figure 18 SNP density in genes that contain an internal hotspot compared to 
genes that do not contain an internal hotspot ..................................... 71 
Figure 19 Length of genes that contain an internal hotspot compared to genes 
that do not contain an internal hotspot ............................................... 73 
Figure 20 Position of genes on chromosome ...................................................... 75 
Figure 21 Comparison of hotspot position in disease-associated genes versus the 
hotspot position of the genes in the control set .................................. 77 
 
 
 
 
 
 
 xvii 
 
Table of Figures (cont..) 
 
Figure 22 Frequency of recombination of internal hotspots of disease genes 
compared to the frequency of recombination of internal hotspots of the 
genes in the control set ....................................................................... 79 
Figure 23 Frequency of recombination of the highest scoring hotspot for each 
disease-associated gene compared to the highest scoring hotspot for 
each gene in the control set ................................................................ 81 
Figure 24 Score Metric of disease-associated genes compared to the score metric 
of the genes in the control set ............................................................. 83 
Figure 25 Relationship between gene length and the presence or absence of 
recombination hotspots  ..................................................................... 88 
Figure 26 Comparison of the median gene lengths of disease-associated genes 
and the genes in the control set  ......................................................... 90 
Figure 27 Hotspot frequency of recombination per chromosome  ..................... 95 
 
 
 
 
 
 
 
 
 1 
 
CHAPTER ONE 
   Background and Introduction 
 
In recent years there have been hundreds, if not thousands, of candidate disease 
genes predicted by genome-wide studies that have been performed on large groups of 
patients, as well as animal experimental models of disease, and cell culture models of 
disease. It is for this reason that the objective of present-day computational 
approaches to disease-associated gene identification is to try to isolate the ‘most 
likely’ disease gene candidates for further empirical analysis by translational 
researchers so that this massive amount of information can be put into practical 
applications (Tiffin et al., 2006; Tiffin et al., 2009). Computational disease gene 
predictions attempt to efficiently identify genes of diagnostic, prognostic and 
therapeutic value for further experimental validation. The data used for 
computational analysis include gene structure and sequence data, functional 
annotation of candidate genes, the characteristics of known disease genes, gene 
regulatory networks and protein-protein interactions, and data from animal models 
and disease phenotype. There is however, a negative aspect of these methods. They 
are typically developed using training sets and training data that are mainly 
Eurocentric (Tiffin et al., 2006; Tiffin et al., 2009). This Caucasian-centric bias is 
regularly shown in genome-wide association studies (GWAS). The participation ratio 
for a GWAS is usually ~10:1 individuals with European ancestry compared to all 
other ethnic groups combined (http://www.genome.gov/gwastudies). Also, the 
majority of the GWAS that do involve non-European ethnic groups generally include 
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smaller sample sizes than those with participants of European ancestry. There are a 
number of reasons for this bias; (1) better funding for Caucasian-centric studies, the 
majority of researchers with sufficient funding for GWAS come from Europe and 
USA where the population base is predominantly of European ancestry, and (2) there 
is an increased population complexity in African populations (Need and Goldstein, 
2009), the African continent has the second largest population (after Asia) and this 
implies greater diversity between subgroups in Africans resulting in an increased 
likelihood of population stratification. This creates a need for larger sample sizes and 
more complex analysis. 
In this thesis, I investigate the possibility of a fresh approach to enable disease-
associated gene prediction, using the position of genes within the genome structure. 
This approach is novel because it is the first of its kind to investigate whether the 
distance of a gene from a recombination hotspot and the frequency of the 
recombination at that hotspot may be related to the likelihood that a specific gene is 
the underlying cause of a specific disease.  This could therefore, be seen as a pilot 
study to investigate other possible approaches to predicting “most likely” disease-
associated gene candidates, by analyzing the relationship between disease-associated 
genes and genome structure. Since epidemiological evidence has clearly and 
consistently shown that disease occurrence and genetics underlying disease can vary 
substantially between populations and ethnic groups (Via et al., 2009) if such a 
relationship between gene and genome structure exists, it will provide a novel way of 
prioritising disease genes in a population/ethnic-specific way based on the unique 
haploblock structure of populations.  
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The remainder of this chapter will provide the background to the study, as well as 
reviews current knowledge and the state of the art in this field. 
Chapter 2 outlines the materials and methodology used in the study. This includes, a 
description of the process used for the assembly of training gene sets, the scoring 
system used to describe the relationship between the gene and its flanking 
recombination hotspots, and the analysis used to compare the score distribution for 
disease-associated genes and genes with no reported association or function in any 
known disease, hereafter referred to as the ‘control set’. 
Chapter 3 describes the results of the study and particularly the differences and 
similarities in the scores of the genes in the control set. It also describes the results of 
analysis done on the collective list of the same genes (disease-associated and control 
set) that have been separated into genes that contain an internal hotspots compared to 
genes that have no internal hotspots.  
In chapter 4, the likelihood of whether a gene underlying a disease might be due to 
the effect of a genes proximity to the recombination hotspots and frequency of 
recombination at these hotspots is discussed. This chapter also outlines the strengths 
and limitations of the study as well as presenting directions for future research. 
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1.1. The Process and Mechanisms of Homologous Recombination   
Genetic recombination is a crucial element of evolution and forms the basis of our 
genetic history. Genetic recombination plays two essential biological roles; it 
guarantees the consistent transfer of genetic information from one generation to the 
next and it generates new combinations of genetic variants (Zhang et al., 2009). 
There are two types of genetic recombination; homologous DNA recombination 
where genetic material is exchanged between different regions of two sister 
chromatids and, the far rarer, non-homologous DNA recombination where genetic 
material is exchanged between different chromosomes. Due to the fact that it is less 
likely to occur naturally, it is the frequency of non-homologous recombination that 
has key implications for genetic reliability, genetic progression and more 
importantly, human disease.  
Non-homologous recombination, involves the exchange of genetic material between 
different chromosomes. Non-homologous recombination repairs double-strand 
breaks in DNA without the need for a homologous template. The repair is guided by 
short homologous DNA sequences called micro-homologies that are present in 
single-stranded overhangs on the ends of double-strand breaks. Non-homologous 
recombination has been implicated in many diseases (reviewed in Chen et al., 2010) 
and can also lead to insertions and deletions as well as to translocations and telomere 
fusion (reviewed in Chen et al., 2010 and Baird. 2008).  
Homologous DNA recombination, involves the exchange of genetic material 
between two highly similar or even identical molecules of DNA. In humans, this is 
an essential process occurring during meiosis where genetic materials are exchanged 
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between two newly duplicated chromosomes. These chromosomes can be divided 
into two types; autosomes and sex chromosomes. Human somatic cells contain 23 
pairs of chromosomes (22 autosomes pairs and one pair of sex chromosome (XX in 
female and XY in male)).  
As this thesis focuses on hotspot recombination within genes on the chromosome it is 
important to note that 95% of the human Y chromosome is unable to recombine with 
the X chromosome, except for small pieces of pseudo-autosomal regions at the 
telomeres (remaining 5%) and therefore, for our purpose, the X chromosome and Y 
chromosome will be considered as one. 
1.1.1. Meiosis and Crossing over 
In sexually reproducing organisms, such as humans, meiosis takes place in 
specialized diploid (46) cells called zygotes and results in haploid (23) daughter cells 
with only one set of homologous chromosomes (Figure 1). During meiosis, a 
homologous chromosome pair, consisting of a chromosome from the mother and a 
chromosome from the father, aligns along the centre of the nucleus and exchanges 
sections or fragments of chromosome in a process of the recombination referred to as 
“crossing over”. Crossing over can cause alleles, previously on the same 
chromosome, to be separated onto two different chromosomes. The further apart the 
alleles are on the original chromosome, the greater the chance that a cross-over event 
will occur and the greater the chance that the alleles will be separated after crossover. 
Crossing over produces a new and unique chromosome containing genetic 
information different from the parents, and hence, is referred to as DNA 
recombination. 
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Figure 1  The Stages of Meiosis – An Overview  
Meiosis begins with one diploid cell (46) containing two copies of each 
chromosome, one from the mother and one from the father and results in four haploid 
cells (23) containing one copy of each chromosome. There are two major phases of 
meiosis, meiosis I and meiosis II. During meiosis I, the parent cell has two sets of 
chromosomes (diploid) and each single cell divides into two. During meiosis II, 
those two cells each divide into four daughter cells containing a single set of 
chromosomes each (haploid). 
(Adapted from URL: http://t1.gstatic.com/images) 
 
Parent cells 
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1.1.2. The Holliday Junction 
The most widely accepted model for DNA recombination was first proposed by 
Robin Holliday in 1964 (Holliday, 1964) and is based on the formation of a 
‘Holliday junction’ as shown in Figure 2. 
A ‘Holliday junction’ is formed when two double-stranded DNA molecules (one 
from each parent) separate into four strands in order to exchange segments of genetic 
information. This occurs during meiosis when a double strand break (DSB) occurs on 
one of the chromosomes. This break allows for sections of the DNA surrounding it to 
be degraded by an enzyme thereby creating a single strand DNA that has the 
potential to bind to homologous DNA on another chromosome. The Holliday 
junction can resolve in two possible ways; gene conversion or crossing over. In gene 
conversion, small amounts of DNA sequence information are transferred between 
chromosomes having no effect on the subsequent gametes. In crossing over, much 
larger sections of DNA sequence information are exchanged and this has a much 
greater effect on the subsequent gametes, as all genetic material beyond the 
recombination points is exchanged. 
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Figure 2 Holliday model of recombination  
The Holliday model for homologous recombination shows single-strand breaks 
occurring at the same point on one strand of each parental DNA. The free ends of 
each broken strand then migrate across to the other DNA helix, where both strands 
are joined together. The resulting crossover junction is called a Holliday junction. 
Depending on how this structure is resolved either cross-over or gene conversion 
products result.  
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1.1.3. The CentiMorgan 
The unit for measuring the rate at which recombination occurs on a DNA molecule is 
called the centiMorgan (cM). It is usually calculated in terms of the expected number 
of recombinations that occur between two loci per generation. One centiMorgan is 
equal to a 1% chance that in a single generation a marker at one genetic locus on a 
chromosome will be separated from a marker at a second locus due to crossing over 
(Figure 3). In other words, if two loci are 1cM apart then during meiosis they will 
recombine on average 1 out of 100 generations. Since the unit is incremental, if two 
loci are separated by 40cM then one would expect to observe forty recombination 
events on average per generation between the two loci. Reference, however, is 
seldom made to distances greater than 50cM as this would imply a recombination 
rate of greater than 50% and would be equivalent to random assortment. This would 
then suggest that the loci are either on separate chromosomes or that the distance 
between the two was too great to be of any significance.    
The genetic distance between two genes can be estimated by calculating the number 
of offspring that exhibit two linked genetic traits and then estimating the percentage 
of offspring where the traits are not linked. The higher the percentages of offspring 
that do not show both traits, the farther apart on the chromosome the two genes are. 
Genes with a percentage value lower than 50% are referred to as linked.  
 
 
 
 
 
 
 
 10 
 
 
 
 
 
 
 
 
 
 
Figure 3 Illustration of the CentiMorgan  
A centiMorgan is the unit of genetic distance that represents a percentage probability 
of recombination during meiosis. If two genes are 5 cM apart, there is a 5% chance 
they will break apart during meiosis.  
 
 
 
 
 
Physical distance in 
Megabases (Mb) 
Genetic distance in 
centiMorgans (cM) 
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1.1.4. Gene Mapping 
There are important applications for gene mapping in research; (1) it is useful in 
locating the position of genes on a chromosome. For example, if two genes are 
linked and the position of the first gene is known the position of the second gene can 
be assumed as it must be within close proximity, (2) it is valuable for estimating 
genetic risk. For example, if a gene cannot be investigated directly, then one could 
use a variation found at a closely linked locus to identify the presence or absence of 
an unfavorable allele. 
Gene mapping can be done by either building a physical map or a genetic map. A 
physical map illustrates the actual physical location of genes on a chromosome while 
a genetic map represents the distribution of a set of genes on a chromosome with the 
distance between loci expressed as percent recombination, or centiMorgan. In 
humans, the rate of recombination on most chromosomes is lower in males than in 
females and therefore female genetic maps are longer than male genetic maps. On 
average, the genetic maps of females are 90% longer than the same maps in males 
however, the base pair number per chromosome remains the same and therefore their 
physical maps are identical.  
The standard method for studying the rate of recombination in the human genome 
begins with building a genetic map (Figure 4). Genetic maps can be constructed 
using family-based linkage analysis. Linkage analysis is done by using the genotypes 
of a notable number of individuals within a family to identify sufficient numbers of 
genetic markers that can be used to determine chromosomes in current generations 
that are recombinants of those in earlier generations. This data can then be used to 
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calculate the number of recombination events between markers and to show the 
position of its known genes, or genetic markers, relative to each other in terms of 
recombination frequency (in centiMorgans). Due to the difference in genetic maps 
between males and female, the frequency of recombination rate between males and 
females also differs. The distance in cM can be given as either female or male based 
or alternatively a sex-averaged map can be constructed using the “sex-average” 
distance in cM between the two loci. 
Comparisons between genetic maps and physical maps have shown that some 
regions of chromosomes are more likely to be involved in crossing over than others. 
These regions are referred to as recombination hotspots and are approximately one or 
two thousand base pairs (bp) in length. These hotspot regions are, in turn, flanked by 
“cold spot” regions. These are sections on the chromosome where the frequency of 
recombination is lower than average (Lichten et al., 1995). Recombination hotspot 
regions are investigated in this study due to their potential effect on DNA sequence 
variation in human chromosomes and because these regions could possibly be used 
to identify alleles that cause disease. 
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Figure 4 Comparison of a Genetic map and Physical map   
A genetic map, as illustrated on the right, shows the genes on a chromosome with the 
distances between loci given in centiMorgans, i.e. as a percent of recombination. A 
physical map, as illustrated on the left, describes the physical location of genes on 
chromosomes.  
(Received from URL: 
http://t1.gstatic.com/images?q=tbn:ANd9GcSurlxYn3ZxkuyWeSPnCaRH7vNuSSXi
yOGP9f24NidNJAluAW5hsg) 
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1.1.5. Haploblock Structure 
In humans, 99.5% of our DNA sequence is identical. It is however, the variations in 
our DNA that affect an individual’s susceptibility to disease risk. A variation at a 
single base pair, called a SNP, can have a significant influence. A haplotype is a 
combination of alleles at multiple linked loci that an individual will inherit as a unit 
from the parent and are common to related individuals. A haploblock is a set of SNPs 
on the same chromosomes that are inherited as a block and are common in unrelated 
individuals. These ‘haploblocks’ indicate regions on the chromosome that have not 
been altered by recombination.  
1.1.6. Linkage Disequilibrium 
As discussed earlier in the chapter, the frequency of recombination is a measure of 
the genetic distance between two sites on a chromosome. At a recombination 
frequency of 1%, two loci will separate once in every 100 recombinations during 
meiosis. Loci separated by >50cM are said to be unlinked as recombination has 
reached a maximum of 50%. In this scenario there is an equal chance that the loci 
could stay together or separate during meiosis. As the distance between two loci 
decreases and eventually reaches 0cM for loci that are very close to one another, the 
recombination frequency will reach 0% and the level of linkage will increase. In 
other words, at 0cM distance, there is only one possible conclusion, the loci are 
linked. This indicates that equilibrium is impossible, and hence crossing over will 
never occur and the two loci are said to be in linkage disequilibrium (Figure 5). In 
this scenario the loci, as well as the entire region between them, will be inherited as a 
single unit (Micklos and Freyer. DNA Science: A First Course, 2
nd
 Edition). 
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Figure 5 Linkage Disequilibrium   
Two loci are in linkage disequilibrium (LD) when pairs of alleles from the two loci are inherited together in the same gametes more often 
than expected at random from their corresponding alleles frequencies.  
On the left, two loci, locus A and locus B, each one with two alleles (A,a and B,b) and allele frequencies as pA=pa=0.5 and pB=pb=0.5. 
Locus A and B are in linkage equilibrium (LE) when the frequencies of the four possible gametes AB, Ab, aB, and ab are:  
 pAB = pApB= 0.25 pAb = pApb = 0.25 paB = papB = 0.25 pab = papb = 0.25 
And the sum of the gamete frequencies equals 1. 
On the right, the actual gamete frequencies are different from what it is expected under LE and shows that locus A and B are in linkage 
disequilibrium:  pAB = pApB= 0.40 pAb = pApb = 0.10 paB = papB = 0.10        pab = papb = 0.40 
(URL http://www.biometris.wur.nl/UK/Tutorial+on+LD+mapping/Concepts+and+definitions/What+is+LD/)
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1.2. Characterising Recombination Hotspots 
As previously mentioned, recombination hotspots are regions within the genome 
where increased rates of recombination occur (Lichten & Goldman 1995). Research 
has shown that most hotspots share morphological traits such as structure and 
appearance. These homologous traits infer a more recent common ancestor, and can 
be used to reconstruct evolutionary histories. On estimate, a hotspot is in the region 
of 1.5 to 2.0 kilobases in length. 
1.2.1. The International HapMap Project 
Recombination rates, and therefore identification of recombination hotspots, have 
been calculated at a genome-wide level (Myers et al., 2005), using the data presented 
by the HapMap consortium (The International HapMap Consortium 2005, URL: 
www.hapmap.org). Although understanding of the nature of chromosomal 
recombination hotspots across the genome is limited (Li and Stephens, 2003; Stumpf 
and Goldstein, 2003; McVean et al., 2004; Frazer et al., 2007) some analyses have 
didentify short motifs that are associated with recombination hotspots (Myers et al., 
2008). Data regarding recombination rates and hotspots can be accessed and 
downloaded by population from the HapMap website, and resources are available at 
this, and other, public databases for viewing the data (Barnes 2006; Frazer et al., 
2007). 
The HapMap project was designed to create a public-access database identifying 
patterns of common sequence variations. The aim of the project is to create a central 
database of human genetic variation that can be used for genetic studies of human 
health and disease (Manolio et al., 2008). The data was collected from several 
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populations from different ancestral geographic locations to ensure that the HapMap 
included most of the common variation and some of the less common variation in 
different populations. First initiated in 2002, the aim was to identify genetic 
variations distributed amongst the different population groups, by identifying SNPs 
spaced at approximately 5-kilobase intervals with a minor allele frequency of at least 
5%. 
The HapMap project studied the linkage disequilibrium (LD) relationships across the 
human genome in four different ethnic groups (The International HapMap Project, 
2003). These included a panel of 30 trios from the Yoruba, Nigeria (YRI); a panel of 
30 CEPH trios from US Utah residents with European ancestry (CEU); and a panel 
of 45 unrelated Japanese individuals from Tokyo (JPT) and 45 unrelated Han 
Chinese individuals from Beijing (CHB). The two statistical measures of linkage 
disequilibrium, used by the project are; (1) D′ - if two SNPs have not been separated 
by recombination during the history of the sample, then D′ = 1, and (2) r2 - when two 
alleles are always observed together then r
2
 = 1. 
As previously mentioned, there are 22 autosome pairs, and one pair of sex 
chromosomes, XX in females and XY in males. Since only two portions of the Y 
chromosome are homologous with the X chromosome, and hence do not recombine, 
these are not genotyped in the HapMap database and therefore do not feature in the 
analysis. 
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1.3. Current Protocols for Estimating Recombination Rates 
In review, recombination frequency refers to the rate with which a single 
chromosomal crossover will take place between two genes during meiosis and is 
measured by counting the number of recombinant offspring and dividing it by the 
total number of offspring (Hudson, 1987).  In humans, it has been possible to 
construct whole-genome genetic maps by scoring markers across the entire genome 
based on three methods for estimating recombination rates; (1) sperm typing, (2) 
pedigree data analysis and (3) by studying linkage disequilibrium (Zheng et al., 
2010).   
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1.4. Defining a Gene and Gene Features 
The genes included in both the disease-associated gene list as well as list of  genes 
that have not been documented with a disease association (the control set) can be 
separated into three types; protein-coding genes, non protein-coding genes 
(pseudogenes), and RNA. Below is a brief description of each as well as the 
justification for including these genes in this study. 
Protein-coding genes are heredity DNA units passed from parent to offspring that 
code for a protein. These are the genes responsible for the physical and inheritable 
characteristics or phenotype of the offspring. Protein-coding genes include exons, 
which code for the amino acid sequence of the protein; introns, which contain 
regulatory regions and splicing sequences elements.  The UTR regions are found at 
both the 5’ and 3’ ends of the gene and contain regulatory elements. UTR regions are 
included in the analysis as mutations in these regions could affect the expression of 
the gene and hence could influence disease phenotype (Chen et al., 2006, Pickering 
and Willis. 2005). 
MicroRNA (miRNA) is a short ribonucleic acid (RNA) molecule found in eukaryotic 
cells and is usually only a few nucleotides in length. miRNAs have been included in 
the study as several of these molecules have been found to have links with human 
disease (de Pontual et al, 2011, Thum et al., 2007) as well as in cancer (Farazi et al., 
2011, Thomson et al., 2005). For example, microRNA-21 was one of the first 
microRNAs to be identified as an oncogenic-associated microRNA. 
Pseudogenes are a subset of non protein-coding genes and are dysfunctional 
paralogues of their functional counterparts but have lost their protein-coding ability. 
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Pseudogenes were included in the study for several reasons. Firstly, there have been 
pseudogenes previously implicated in disease (McEente et al., 2010). These, 
therefore, fit our criteria for the disease gene set and should consequently also be 
included in the control set. Secondly, the definition of a pseudogene is inconsistent 
and many pseudogenes have been subsequently predicted to have biological 
functions (reviewed in Svensson et al., 2006). The removal of pseudogenes from the 
control set is unlikely to be accurate based on the poor understanding of how to 
determine if a gene is non-functional. The fact that the estimated range of 
pseudogenes in humans is between 3600 and 20000 (Svensson et al., 2006, Ohshima 
et al., 2003) gives an indication of how inconsistent not only the figures are but also 
the definition of what a pseudogene actually is. The expression products have been 
found for 4-6% of pseudogenes and this too is likely to be an underestimation 
(Harrison et al., 2005). Lastly, pseudogenes have very similar sequences to their 
functional counterparts with sequence conservation of an estimated 67% and 
inclusion of these genes is therefore unlikely to affect or skew analysis of gene 
characteristics in the control set (Svensson et al., 2006). There is also evidence of 
conservation and functionality of pseudogenes in mouse and drosophila (Balakirev 
and Ayala, 2003). 
Figure 6 illustrates the gene including the coding and non-coding regions. The 
coding region of a gene's DNA or RNA codes for proteins and is composed of exons. 
The transcription start codon binds the region nearer the 5' end while the stop codon 
is nearer the 3' end. The 5’ untranslated region (UTR) begins at the transcription start 
site and ends just before the start codon (usually AUG) of the coding region. The 3’ 
UTR region starts with the nucleotide immediately following the stop codon of the 
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coding region. The 5’- and 3’ UTR regions are contained within exons but do not 
code for amino acids. 
For the analysis, I have reviewed certain gene features of known disease-associated 
genes and compared them to a control set (see Table 1). These include gene length, 
base composition (GC content), genetic variation (SNP count and SNP density), 
positional effect (distance of a gene from the chromosome end depending on its 
location with respect to the centromere), and recombination hotspots 
(presence/absence of a recombination hotspot within the gene or distance from 
nearest hotspot and frequency of recombination of internal/nearest hotspot). 
For the purpose of this thesis a gene includes 5’UTR, exons, introns and 3’UTR. The 
GC content and genetic variations (SNP count) were both pre-calculated values 
obtain from the Ensembl database version 65. A chromosome has two arms, 
commonly referred to as the p arm and q arm, which are separated by the centromere. 
The position effect (distance to chromosome end) was calculated separately for each 
arm by comparing gene position to centromere position individually for each 
chromosome. For the p arm distance, distance from chromosome end was calculated 
by subtracting the chromosome start (0) from the position of the start of the gene. For 
the q arm distance, distance from chromosome end was calculated by subtracting the 
position of the end of the gene from the position of the chromosome end. It is 
important to note that the centromeres are based on Ensembl assemble GRCh37 and 
are averaged at a length of 3 million base pairs each. This is due to the fact that the 
centromeric region of a chromosome is hard to sequence accurately because it is 
heterochromatic. Frequently, sequencing centers simply report centromeres as gaps. 
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Figure 6  Illustration of the Human gene 
The coding region of a gene's DNA or RNA codes for proteins and is composed of exons. The transcription start codon binds the region 
nearer the 5' end while the stop codon is nearer the 3' end. The 5’ untranslated region (UTR) begins at the transcription start site and ends 
just before the start codon (usually AUG) of the coding region. The 3’ UTR region starts with the nucleotide immediately following the 
stop codon of the coding region.. The 5’- and 3’ UTR regions are contained within exons but do not code for amino acids. 
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Table 1   Gene Feature Directory 
The list of features reviewed in known disease-associated genes compared to the control set. 
 Database Description Resource 
GC content   
 Martview GC content as a % of gene http://www.ensembl.org/biomart/martview/ 
SNP density   
 SNPMart 65 Number of SNPs per 10kbp ftp://ftp.ensembl.org/pub/release-65/mysql/snp_mart_65/ 
Gene Length   
 EnsemblMart 65 Length of gene in bp ftp://ftp.ensembl.org/pub/release-65/mysql/ensembl_mart_65/ 
Position   
 EnsemblMart 65 Shortest distance of gene to chromosome end ftp://ftp.ensembl.org/pub/release-65/mysql/ensembl_mart_65/ 
Recombination   
 HapMap Rate of recombination per gene http://hapmap.ncbi.nlm.nih.gov/downloads/recombination/ 
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1.4.1. Base Composition: percentage GC content 
The GC-content of a gene refers to the percentage of guanine or cytosine nitrogenous 
bases present in a DNA molecule. As the GC bases pair by three hydrogen bonds as 
opposed to the AT (adenine/thymine) bases that pair only by two hydrogen bonds, 
DNA with a high GC-content is more stable than DNA with a low GC-content. The 
GC content of human DNA varies extensively across the entire human genome from 
between 30% to 60%. Nonetheless Spencer et al., 2006 and Fullerton et al., 2001 
found that there was an increase in GC content that is highly localized to 
recombination hotspots. One explanation for this is that GC-rich regions promote the 
occurrence of hotspots, and this assumption is supported by the association between 
recombination hotspots and the occurrence of double-strand breaks in GC-rich 
regions (Mucha et al., 2000). Freudenberg et al., 2009 used partial correlation 
analysis to determine a casual relationship between GC content, exon density and 
recombination rate in the human genome.  The Zhao et al., 2003 study found that the 
distribution of SNPs among the gene structure categories, both intergenic and genic 
(intron and exonic) was dependant on the GC content of chromosomes. 
1.4.2. Genetic Variation: Single Nucleotide Polymorphisms (SNPs) 
Genetic variation can be described on two tiers; firstly, at population level, where 
genetic variation is depicted as a percentage of allele frequency in a population; and 
secondly at individual level, where genetic diversity occurs either as homozygous or 
heterozygous at a specific locus. With the increase in the number of sequenced 
genomes the available data on genetic variation has increased substantially and this 
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has the added benefit of the inclusion of many more rare variations (for example, 
SNPs with low minor allele frequencies). 
The average number of differences between genome of two individuals remains 
relatively constant at a rate of approximately 0.1% of nucleotide sites, on average, 
one variant per 1000 base pairs (Wang, 1998). 
The most common type of genetic variation in the human population is called a 
single nucleotide polymorphism, or SNP. There are an estimated 10 million common 
SNP sites constituting 90% of the variation in the population (Reich et al., 2003). 
Figure 7 illustrates that SNPs are single-nucleotide substitutions of one base for 
another. In the human genome, each SNP location can have only four different 
versions: one for each nucleotide, adenine (A), cytosine (C), guanine (G) and 
thymine (T). In order to be classified as a SNP, a minimum of two versions of a 
sequence must occur in at least 1% of the population. There are approximately 10 
million SNPs within the 3-billion-nucleotide human genome which translates to 
about one in every 300 nucleotide base pairs. 
SNPs occur throughout the genome and can act as biological markers to track an 
associated disease, or the inheritance of disease genes within families and/or to 
predict the risk of certain individuals to develop a particular disease (Genetic Home 
Reference handbook, US National Library of Medicine URL: 
http://ghr.nlm.nih.gov/handbook/genomicresearch/snp). They can be used as markers 
to compare regions of the genome between cohorts, i.e. individuals presenting the 
disease versus those who do not. SNPs are also helpful for locating a gene that 
produces phenotypically different individuals (Zollner and von Haeseler, 2000). 
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Researchers have found that ordinarily SNPs are not responsible for a disease state 
but instead serve as biological markers for locating a disease on the human genome 
map. This is due to the fact that SNPs associated with a disease are usually located in 
close proximity to the gene associated with a certain disease (Folkersen et al., 2010).   
For this reason SNPs can be used to search for and isolate the disease-causing gene 
by using association studies to detect differences between the SNP patterns of the 
two groups and, thereby indicating which pattern is most likely associated with the 
disease-causing gene (Just the Facts: A Basic Introduction to the Science Underlying 
NCBI Resources URL:http://www.ncbi.nlm.nih.gov/). 
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Figure 7 Single Nucleotide Polymorphisms (SNPs) 
SNPs are single-nucleotide substitutions of one base for another. In the human 
genome, each SNP location can have only four different versions: one for each 
nucleotide, adenine (A), cytosine (C), guanine (G) and thymine (T). In order to be 
classified as a SNP, a minimum of two versions of a sequence must occur in at least 
1% of the population. There are approximately 10 million SNPs within the 3-billion-
nucleotide human genome which translates to about one in every 300 nucleotide base 
pairs (URL http://learn.genetics.utah.edu/content/health/pharma/snips/). 
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If SNPs are randomly distributed across the genome, one can assume that the 
difference in SNP count per gene could be proportional to the length of the gene. 
This was confirmed by Zhao et al., 2003 with a finding that the number of SNPs per 
chromosome was correlated with the length of the chromosome. They estimated that 
there was on average 8.33 SNPs per 10kb across the genome. 
As discussed earlier, as more populations' genomes are sequenced, the number of 
known SNPs increases, and so these values may reflect the limits of our knowledge, 
in 2003 and today, rather than the absolute number of SNPs. This is especially true 
given the fact that African genomes are the most diverse and yet only a very limited 
number have been sequenced (The 1000 Genomes Project Consortium, 2010). It is 
therefore probable that the SNP density data may change as our knowledge base of 
human genomes increases. 
Also important to note is that the genome structure and genetic variation differ 
considerably between different populations, but African populations, in particular, 
are more genetically diverse than European and Asian populations. This is generally 
believed to be the result of a bottleneck that occurred when population groups 
migrated out of Africa, from where it is thought that humans originated. This is 
known as the “Out of Africa” hypothesis (Stinger et al., 1988). Nucleotide diversity 
and haplotype diversity decrease in populations according to their geographic 
distance from Africa (Teo et al., 2005; Conrad et al., 2006; Jakobsson et al., 2008; 
Tishkoff et al., 2009). 
Table 2 classifies SNPs found in both the coding and non-coding region of a gene 
and describes their functional effects in humans. 
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Table 2 Functional effects of SNPs. 
SNPs are found in both the coding and non-coding region of a gene and have different functional effects in humans. 
Type  Properties 
Coding region  
Synonymous  Both alleles produce the same polypeptide sequence 
Nonsynonymous Both alleles produce a different polypeptide sequence 
Nonsense Results in a premature stop codon 
Missense Results in a different amino acid 
  
Non-coding region  
Promoter/regulatory region Does not change the amino acid, but can affect the level, location or timing of gene expression 
Upstream Change the sequence without any known transcription factor binding site 
Enhancer Alter the binding site for a transcription factor 
Gene Splicing Site  Break the consensus splicing site sequence 
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Figure 8 shows that there is a very strong correlation between the number of SNPs 
per chromosome and the length of the chromosome. Therefore, I have also reviewed 
SNP count and SNP density per 10kb to determine if these are related to gene status 
and whether there is a difference in the degree of variation between disease genes 
and the control set. 
1.4.3. Gene Length 
Research has shown that proteins known to be associated with human disease show a 
clear trend for being longer than the rest of the proteins in the human genome. For 
clarity, a protein is involved in a disease when its analogous gene has impaired 
function of expression due to a mutation that is so severe that it produces a certain 
phenotype that is classified as disease (Lopez-Bigas et al., 2004, Adie et al., 2005). 
The Lopez-Bigas study concluded that the average length of a disease protein is 699 
amino acids, while the average lengths of non-disease proteins range from 460 to 
508. The Adie et al study found that the median length of disease genes, those found 
in OMIM, was 27kb while those genes not found in OMIM have an average length 
of 19kb. These results are endorsed by the fact that during DNA replication, the 
mutation rate could be as high as 1 mistake per 100 (10-2) to 1,000 (10-3)  
nucleotides and that at this rate there is a substantial escalation in the risk of disease-
causing gene mutations in longer genes compared to shorter genes (Johnson et al., 
2000). 
Table 3 illustrates the difference in protein length and gene length that has been 
published in previous literature.
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Figure 8  SNP number per chromosome (based on Ensembl build GRCh37.p7, Feb 2009) 
An illustration of the total number of SNPs per chromosome versus the chromosome length shows that there is a correlation between the 
two suggesting that the SNP count is proportional to the chromosome length. (Data obtained from Ensembl). 
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Table 3  Previously reported data of gene and protein length 
Illustration of the comparative results of protein length, calculated in amino acids, and gene length, calculated in base pairs, reported in 
previous literature. 
 
DISEASE 
Results References Data Source 
Protein length  699 amino acids Lopez-Bigas et al., 2004 1567 genes associated with hereditary 
diseases in humans and their protein 
sequences 
OMIM 
Gene length  27kb  Adie et al., 2005  1,084 genes OMIM 
     
NON-DISEASE     
Protein length  460-508 amino acids  Lopez-Bigas et al., 2004  10 000 similarly sized protein sets selected 
from all the human genome proteins 
Ensembl 
v15.33.1 
Gene length 19kb Adie et al., 2005 ~ 18,000 known genes not known to be 
involved in human disease 
Ensembl 
(2005) 
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1.4.4. Position Effect: Distance from chromosome end 
The theoretical basis for investigating the effect of the physical distance that a gene 
lies from the chromosome ends, based on its position in relation to the 
telomere/centromere and gene-start or gene-end, is the possibility that more 
recombination may occur in regions closer to chromosome ends, as they may have 
more flexibility to enable recombination. 
Once the human genome sequence was compiled and analyzed by the International 
Human Genome Sequencing Consortium in 2001 it was confirmed that the rate of 
recombination near the centromere, or region between the p and q arm, is generally 
repressed while the rate generally increases near the telomeres, or chromosome ends 
(Ames et al., 2008, International Human Genome Sequencing Consortium, 2001). 
A chromosomal break can cause a “loss-of-function” phenotype by disrupting the 
coding sequence of a gene, or by separating the gene from its adjacent regulatory 
region. It could, alternatively, initiate a “gain-of-function” phenotype by splicing the 
regulatory sequences from one gene to the coding sequences from another gene and 
causing alternate expression. In either instance, the breakpoint provides an invaluable 
clue to the exact physical location of the disease gene. A pitfall to this is that 
sometimes, due to the tertiary structure and folding dynamics of the DNA molecule, 
breakpoints can alter expression of a gene located hundreds of kilo base pairs away. 
Adie et al., 2005 found that there was a noteworthy difference (p<0.01) in the 
distance of a disease gene to the nearest neighbouring gene with a median value of 
52kb, while genes not known to be involved in disease had a median distance of 
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46kb (Adie et al., 2005).  To my knowledge, however, there are no published figures 
on the distance of a disease gene or non-disease gene to the chromosome end. 
Figure 9 gives a very broad illustration of the position of all known protein-coding 
genes as well as other genes (novel protein-coding genes, Pseudogene, miRNA 
genes, rRNA, snRNA genes, snoRNA genes, and other miscellaneous RNA genes) 
on the chromosome in relation to the chromosome ends showing that, in general, 
genes are fairly evenly distributed along the chromosomes. 
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Figure 9  Gene Distribution per chromosome 
A graphical illustration of the position of all known protein-coding genes as well as other genes, such as pseudogenes, on the chromosome in relation to the chromosome ends. This shows that, in general, genes are fairly 
evenly distributed along the chromosomes.                                                       
 (Adapted from URL www.ensembl.org/). 
35 
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1.5. Data Resources  
1.5.1 Online Mendelian Inheritance in Man (OMIM) 
The resource used for disease-associated gene predictions was the Online Mendelian 
Inheritance in Man (OMIM) database (URL: http://omim.org, McKusick-Nathans 
Institute of Genetic Medicine, John Hopkins University (Baltimore, MD) 2012), 
human genome reference assembly GRCh37.3 from October 2011). This is a 
comprehensive and curated database of human genes and genetic phenotypes 
detailing all disease-associated genes (~21 000 genes) that have been implicated in 
disease. The OMIM data is based on published, well-referenced and current 
literature.  At present, OMIM reports ~2800 defective genes or loci that have been 
described conclusively as that cause of “a single disorder with a sole means of 
transmission” (Mendelian diseases), while the remaining entries are described as 
“being of uncertain inheritance”, either because the same condition can result from 
more than one genetic defect (complex diseases), or because the phenotype may 
overlap with another (Parton. 2003). 
The data is freely available and updated daily. This database was initiated by Dr. 
Victor A. McKusick in the 1960’s in order to assemble all known Mendelian traits 
and disorders at one source. In a joint collaboration between the National Library of 
Medicine and the William H. Welch Medical Library at Johns Hopkins, OMIM went 
online in the 1980’s. 
From here on, the following description of what constitutes a gene will hold true for 
all references made to OMIM throughout this study unless explicitly stated 
otherwise; gene includes 5’UTR, exons, introns and 3’UTR. 
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When reference is made to disease-associated genes this includes protein-coding 
genes, non protein-coding genes (pseudogenes) and RNA. The diseases included in 
the OMIM database are no longer exclusively single gene (Mendelian) diseases but 
also include multifactorial diseases, also called complex or polygenic diseases, 
caused by both environmental factors as well as mutations in multiple genes such as 
cancer, chromosome abnormalities, resulting from abnormalities in chromosome 
number and structure e.g. down syndrome and lastly mitochondrial diseases, a 
genetic disorder caused by mutations in the mitochondrial DNA, e.g the eye disease 
called Leber’s hereditary optic atrophy. The genes included in OMIM are genes with 
a direct relationship to these disease and those of known function (Amberger et al., 
2009). 
1.5.2. The Ensembl Project 
In order to distinguish between disease-associated genes and genes not previously 
reported as being implicated in any known disease and to circumvent the problem of 
genes that have not, as yet, been implicated in disease, or false positives, I 
constructed a list of genes from the whole genome, using the Ensembl project 
database (Flicek et al., 2011 URL: http://www.ensembl.org/), and removed all genes 
that were mentioned in OMIM. 
Ensembl is a joint project between European Bioinformatics Institute (EBI), part of 
the European Molecular Biology Laboratory (EMBL), and the Wellcome Trust 
Sanger Institute (WTSI) in Cambridge, United Kingdom started in 1999 prior to the 
completion of the first draft human genome. The main goal of the project was to 
automatically annotate the genome. The idea was to integrate this annotation with 
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other available biological data and make it publicly available via the web in the 
timeliest and most cost effective manner (Flicek et al., 2011). 
Ensembl is an open-source database that offers specific tools for comprehensive data 
analysis and mining with the DNA sequences and assemblies provided by various 
projects around the world. The Ensembl BioMart data-mining tools provide an easy 
to use, generic system, capable of handling large amounts of input data and BioMart 
is able to perform advanced queries of numerous biological data through a single 
web interface (Smedley et al., 2009, URL: 
http://www.ensembl.org/biomart/martview/). The Ensembl data-mining tools used in 
this study are; (1) EnsemblMart version 65, the .ftp file contains the automated 
annotation of eukaryotic genomes and (2) Ensembl SNPMart version 65, the .ftp file 
contains Ensembl variation data from dbSNP and other sources. 
From here on, the following description of what constitutes a gene will hold true for 
all references made to Ensembl throughout this study unless explicitly stated 
otherwise; all genes include the 5’UTR and 3’UTR regions as well as the exons and 
introns. Although one gene may have multiple RNA transcripts, the genomic DNA 
sequence was used to define the gene in this study. 
The Ensembl human gene set, on which the control set is based, includes all protein-
coding genes that have been automatically annotated using Ensembl genebuild 
pipeline as well as all transcripts based on mRNA and proteins in public scientific 
databases. All automatically-annotated pseudogenes and non-coding RNAs are also 
included. 
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1.6  Rationale for current study 
The main motivation for this study stems from the reality that significant changes in 
gene structure as a consequence of recombination are known to underlie diseases. 
Non-homologous recombination has been implicated in many diseases (reviewed in 
Chen et al., 2010), and in particular to translocations. When a translocation occurs a 
segment of a chromosome shifts from one position to another, either within the same 
chromosome or to another chromosome. It is the latter translocation event that can 
result in gross changes to DNA structure. These chromosomal aberrations have been 
shown to be pivotal in tumour development and that ultimately leads to the formation 
of cancer genes, commonly referred to as oncogenes. Even though homologous 
recombination, and genetic variation, is a necessary process it is these extreme 
scenarios where non-homologous recombination introduces a disease phenotype 
through a gross change in variation that lead us to question whether more subtle 
changes in variation, introduced through homologous recombination, could also 
predispose a gene to causing disease through increased variation. Identifying the 
effects of homologous recombination on likelihood of genes to underlie disease 
could offer a novel, population-specific, approach to prioritising good candidate 
genes for further investigation. 
It may soon be possible to extrapolate the occurrence of translocations to the wider 
genome for the purpose of identifying aetiological genes using a similar technique to 
Hamkin et al., 2012. This is because during recombination events, genes that are in 
closer proximity to recombination hotspots are more likely to undergo recombinant 
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events that place them next to variant regulatory sequences, and may therefore be 
more prone to altered or dysregulated expression leading to pathogenic effects.  
The aim was to develop a dataset of disease-associated genes and a control set of 
genes that have not previously been reported as having an association with any 
known disease and to investigate various gene characteristics of these datasets and 
how they relate to the likelihood of a gene to underlie disease. The main issue was to 
determine whether a gene’s proximity to a hotspot is likely to be of universal 
importance to disease gene status or whether it should be considered for a group of 
diseases characterized by chromosomal instability such as the case in cancers. 
The main goal was to use this as a pilot study to investigate whether distance from 
recombination hotspots and frequency of recombination at the hotspot may be related 
to the likelihood of a gene to cause disease. The secondary goal was to attempt to 
identify additional gene features, such as gene length or SNP count, as a supporting 
characteristic to classify disease gene status. These goals could thereby potentially 
identify other criterion that can be used in concert with existing tools in the 
prediction of most likely disease gene candidates.  
This goal was accomplished by answering the following questions: 
(A) A general characterization of the properties of disease-associated genes 
compared to the control set 
When comparing disease-associated gene characteristics to the same characteristics 
of genes in the control set: 
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i. Is there a difference in %GC content in disease-associated genes compared to the 
control set? 
ii. Is there a difference in SNP count and SNP density in disease-associated genes 
and the control set? 
iii. Is there a difference in length between disease-associated genes and the control 
set? 
iv. How does the distance that disease-associated genes and genes in the control set 
sit from the end of the chromosome impact on the gene status? 
(B) A specific characterization of recombination hotspots in disease-associated 
genes compared to the control set: 
When comparing all genes that contain an internal hotspot and genes with no internal 
hotspot: 
v. Is there a difference in %GC content between genes with hotspots and genes with 
no hotspots? 
vi. Is there a difference in SNP count and SNP density in genes with hotspots 
compared to genes with no hotspots? 
vii. Is there a difference in length between genes with hotspots and genes with no 
hotspots? 
viii. How does the distance that all genes with a hotspot and those with no hotspot 
sit from the end of the chromosome impact on gene status? 
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When comparing the recombination hotspot either lying within the gene or nearest to 
the gene: 
ix.  Are disease-associated genes more likely to contain a recombination hotspot 
than genes in the control set? 
x. Do the hotspots lying in disease-associated genes exhibit a higher frequency of 
recombination than the hotspots in genes in the control set? 
xi. Do the hotspots lying nearest to disease-associated genes with no internal 
hotspot exhibit a higher frequency of recombination than the hotspots lying 
nearest to genes in the control set? 
xii. Is there a difference in frequency, distance and overall scoring of hotspots 
nearest to disease-associated genes compared to hotspots nearest genes in the 
control set? 
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CHAPTER TWO 
Material and Methods 
 
This research focuses on the characterization of disease-associated genes and the 
control set of genes with no documented disease association with regards to the 
position of the gene within the genome structure.  
An overview of the methods used to achieve this, as illustrated in Figure10, can be 
divided into four key sections;  
(1) Developing the scoring system 
(2) Compiling of the test sets and assembling of recombination hotspot data 
(3) Collecting gene characteristics 
(4) The data analysis 
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EnsemblMart 65 
A 
Input: ensembl_ID 
File 1 disease_genes.txt 
C 
File 3 disease_gene_coords.txt File 4 non-disease_gene_coords.txt 
File 5 score_output_disease_gene_coords.txt 
File 6 score_output_nondisease_gene_coords.txt 
 
 
Online Mendelian 
 Inheritance in Man 
(OMIM) 
Disease-associated gene set  
 
 Control Set 
 
Figure 10 Overview of methods applied to compilation of test sets and assembly of recombination hotspot data 
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2.1.  Developing the Scoring System 
I developed a pragmatic, empirically determined scoring system to represent the 
distance from recombination hotspots and frequency of recombination at those 
hotspots, for all genes in the genome (Illustrated in Figure 11).  
Score =  Frequency of recombination (in centiMorgans per mega base pair) 
Distance (in mega base pairs) 
This scoring system took into consideration all recombination hotspots on the same 
chromosome as the gene, and the frequency of recombination events at flanking 
hotspots as well as recombination hotspots that lie further away. A pipeline was then 
established to calculate the scores for all genes in a given population. The design 
enables us to use the formula broadly on any populations given the positions of 
recombination hotspots in that population, however since this is a pilot study I 
initially wanted to establish if there was a relationship between hotspots and disease-
associated genes before extending the study to specific populations. 
The scoring system also incorporates the possibility that a gene lies very close to a 
recombination hotspot with a low frequency of recombination events, but that further 
away there may be a recombination hotspot of high frequency of recombination. This 
is because such a high frequency recombination hotspot could potentially have a 
greater effect on co-segregation of the gene with its regulatory sequences than the 
more proximal hotspot. This required a matrix of scores to be established for each 
gene, relating to multiple recombination hotspots in the region surrounding the gene 
and the frequency of recombination at each hotspot. For each disease-associated 
genes all the hotspots on the same chromosome were considered and a score was 
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generated, then the highest scoring hotspot for each disease-associated gene was 
selected for further analysis. In this way the dominant effect of local hotspots on the 
gene was determined. Consideration was also given to the possibility that a 
recombination hotspot occurs within the span of the gene and these instances were 
flagged with an artificially assigned distance value of 0.1. (This value was chosen as 
0.1 cannot be a naturally occurring measure of distance in base pairs). The scoring 
system allowed us to assign a score to each gene according to its relationship with 
nearby recombination hotspots. The score reflects the likelihood that the coding 
section of the gene could recombine causing different combinations of alleles to 
come together; and consequently whether recombination events could cause altered 
functioning of that gene.  
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5’ 3’
Gene NOC2L 
Hotspot co-ordinate: 0.957898 Mb
Rate of recombination: 0.00952858  cM/Mb
Hotspot 2
Figure 11 Graphical illustration of scoring system metric
A graphical illustration showing the concept behind the design of the scoring system used for this study. The hotspot with the
higher score was selected for further analysis. This figure demonstrates that a hotspot with a lower frequency of
recombination (f(x)) lying nearer to the gene has less impact on the gene than a hotspot with a higher frequency of
recombination lying farther away from the gene.
Start: 0.879584 Mb End: 0.894689 Mb
Hotspot 1
Hotspot co-ordinate: 1.497824 Mb
Rate of recombination: 0.075632  cM/Mb
Score = Frequency of recombination (in cM/Mb)
Distance (in Mb)
Score for Hotspot 1 = 0.15
Score for Hotspot 2 =  0.125
 
1.25 
.75632   
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2.2.  Compilation of Test Sets and Recombination Hotspot Assembly  
The first step of this section involved the assembly of a list of genes as control sets. 
There were two sets of genes required to test whether distance/frequency metrics of 
recombination hotspots correlate with the likelihood of a gene to have an aetiological 
role; (1) disease-associated genes; and (2) genes that have no documented association 
with a disease.  
The OMIM database was selected as the source of disease-associated genes for 
several reasons: (1) it represents a very stringent, well curated database that is 
updated daily and therefore contains validated, up-to-date disease 
phenotype/genotype information; (2) only validated gene-disease information is 
included so the proximity to tagging SNPs, as in GWAS studies is not considered 
sufficient evidence to associate a gene with a disease – further evidence is required to 
implicate the gene with the disease. OMIM contains not only information about 
Mendelian diseases but also information of genes implicated in complex diseases, in 
which multiple genes contribute to the disease phenotype but each gene is 
insufficient on its own to cause the disease phenotype. I used the gene list from 
OMIM for both Mendelian diseases and complex diseases because it is known that 
with Mendelian diseases there is a straight forward pattern of inheritance, a single 
gene mutation is sufficient to cause a disease phenotype. However, in complex 
diseases the cause is more difficult to trace. In complex diseases it is a combination 
of factors, such as allele variation or environment, which lead to disease phenotype. I 
hypothesis that if multiple genes work in combination to cause a certain disease 
phenotype, if each of the genes has increased variation due to the proximity to a 
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hotspot then the overall increased variation of all causative genes may still influence 
the likelihood of the combined genes to cause the phenotype. 
I also reviewed other databases such Genetic Association Database (GAD), 
(http://geneticassociationdb.nih.gov/), and Human Gene Mutation Database 
(HGMD), (http://www.hgmd.cf.ac.uk/ac/index.php), as appropriate sources. 
However, I chose to select the OMIM database as the only source for disease gene 
data for the following reasons: (1) OMIM is freely available, (2) there was a high 
level of common genes; (3) less stringent data curation (OMIM data manually 
curated, no automation); and (4) these other databases include negative results of 
association studies which makes disease gene selection complicated. 
The OMIM .ftp file generated a file that included MIM numbers, Entrez gene IDs 
(the phenotype gene IDs were excluded) plus approved gene symbols.  
FTP file: (ftp://anonymous:tracey%40sanbi.ac.za@grcf.jhmi.edu/OMIM/) 
I input the Entrez gene IDs into Ensembl BioMart software, EnsemblMart 65 
database which generated the control set list into a text file (file 1 – 
disease_gene.txt). All duplicate genes were removed. 
The next step was to download the recombination hotspot data. The recombination 
rates and hotspot data were compiled from the genotyping data and these genotypes 
correspond to the four HapMap populations: 90 Caucasian individuals from 30 
CEPH family trios, 90 individuals from 30 family trios from the Ibadan people 
(Nigeria, West Africa), and 90 unrelated individuals from Southeast Asia (45 Han 
Chinese from Beijin, and 45 Japanese from Tokyo). This data was downloaded for 
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the combined populations for the reason that this is a pilot study and I initially 
wanted to establish if there was a relationship between hotspots and disease-
associated genes before extending the study to specific populations. 
Recombination rates and hotspot data were extracted from the bulk data download on 
the HapMap website. Using the HapMap II release 28 data published in August 2010 
based on NCBI B37 assembly. A Python script (cleanup_hotspot_data.py) was used 
to extract the necessary data from the HapMap download, removed all unnecessary 
information and generated a text file (file 2 – hotspots_data_clean.txt). Using the 
Ensembl gene ID as input, I used a Python script (get_gene_coordinates.py) to 
extract the gene co-ordinates as well as the chromosome name from the Ensembl 
database, human genome assembly (GRCh37) version 65, released in December 
2011, contains 23 171 gene models and the manually curated annotation from 
Havana of 45 484 genes to create a final set of 56 478 genes, including coding genes, 
non protein-coding genes (pseudogenes) and RNA genes. This was the data used to 
create the control set of genes from the whole genome. Using file 1 as input, a 
second Python script (hotspot_vs_gene_script.py) divided all the genes in Ensembl 
into two categories. The Python script selected all genes that were previously 
identified by OMIM and separated the data into two text files (file 3 – 
disease_gene_coords.txt, those found in OMIM and file 4 – 
nondisease_genes_coords.txt, all other genes). 
 The output files included the Ensembl gene ID, the gene name, chromosome name, 
and the gene start and gene end co-ordinates for both lists of disease-associated genes 
and the control set.  Using these files the script then selected the top scoring hotspot 
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data for each gene using the scoring system I developed. The data generated two 
output files (file 5 – score_output_disease_gene_coords.txt and file 6 – 
score_output_nondisease_gene_coords.txt). These files contained information for the 
gene (Ensembl ID, maximum score output, chromosome name, gene name and gene 
start and end co-ordinates) as well as hotspot information for that particular gene 
(hotspot position, hotspot frequency and distance of the gene to the nearest hotspot).  
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2.3.  Collecting Gene Characteristics Data  
For the purpose of this thesis I have identified certain gene characteristics that I have 
reviewed between disease-associated genes and the control set. These include gene 
length, GC content, SNP density and distance of a gene from the chromosome ends, 
presence/absence of a recombination hotspot, distance to nearest hotspot and 
frequency of recombination of internal/nearest hotspot. The rationale for this is 
explained in chapter 1. 
2.3.1. Determining Base Composition: GC Content 
The percentage GC content was extracted from the Ensembl BioMart database, 
EnsemblMart_65, by uploading the Ensembl gene ID. Using the ‘Homo Sapiens 
genes (GRCh37.6) dataset, I refined the search by selecting the ID list limit in the 
‘gene’ subheading under the FILTERS table and entered the Ensembl gene ID. Using 
the %GC content under the ‘features’ subheading in the ATTRIBUTES table to 
further refine the search. 
2.3.2. Calculating Genetic Variation: SNP count 
Our SNP density data were obtained using a Python script (get_all_snp_info.py) to 
download all pre-calculated data for SNPs in batches per chromosome from the 
Ensembl BioMart database, SNPMart_65 (December 2011), using Entrez gene IDs. 
A second script (split_genes_by_chrom.py) was used to categorize the SNPs by 
chromosome into disease-associated genes and the control set in order to make SNP 
counting computationally manageable.  
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A third script (get_gene_snp_count.py) was used to count the SNPs for each gene, 
chromosome by chromosome to generate separate output files 
(SNP_count_disease_genes_chrom_(x).txt). The output files included the following 
data; Ensembl gene ID, gene name, gene chromosome name, gene start and gene 
end, gene length as well as SNP count and SNP density. 
2.3.3. Establishing Gene Length 
A Python script (get_gene_coordinates.py) was used to extract the co-ordinates of 
the gene per chromosome from the Ensembl BioMart database, EnsemblMart_65. 
The data, which included gene start (5’UTR) and gene end (3’UTR) positions on the 
chromosome, was input into an Excel spreadsheet and the SUM function was used to 
determine the length of all the genes in both output files (i.e. disease_gene_coords.txt 
and non_disease_gene_coords.txt) by using gene end – gene start.  
 2.3.4. Mapping Position Effect: Distance from chromosome end 
The distance of the gene from the chromosome end was calculated separately for 
each arm. The p arm was calculated using the position of the gene in relation to the 
centromere start position and the q arm was calculated using the position of the gene 
in relation to centromere end position. 
Using the gene co-ordinates (gene start (5’UTR) and gene end(3’UTR)) and the 
centromere start position (p arm) as well as end position (q arm), I calculated the 
distance of each individual gene from the chromosome start, at position 0 base pair, 
by subtracting gene start from chromosome start. I then calculated the distance of the 
gene from the chromosome end, using the chromosome length data from Ensembl, 
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by subtracting chromosome end (or chromosome length) from gene end. The results 
were generated into an excel file, per chromosome (file 7 – 
distance_from_chromo_ends.xls).  I then used the MIN function in to determine the 
shortest distance of each gene from a chromosome end on each arm. 
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2.4.  Data analysis 
In statistics there are two main fields of study: descriptive and inferential. 
Descriptive statistics gives a graphical representation of a data set while inferential 
statistics uses mathematical probabilities by attempting to make the best possible 
conclusion from a small sample of data by extrapolating the data to make inferences 
about the larger population (Introductory Statistics, 2nd Edition (1995) Wiley). This 
thesis focuses on descriptive statistics as the analysis performed is on all the known 
genes in the entire human genome and therefore there is no need to make use of 
inferential statistics to make any assumptions about the larger population. The 
dataset is complete and not a sample from a larger population.  
For this study I use boxplots (Figure 12), a graphical tool for the easy visualization of 
data. The advantages of a boxplot include the ability to graphically display the layout 
and spread of a dataset at a glance, they provide an indication of the data’s symmetry 
and skewness and one can quickly and easily compare more than one dataset side-by-
side. The main attribute of a boxplot is that, unlike other methods for displaying data, 
it shows outliers, points that lie beyond one and a half times the length of the box. 
Mild outliers lie outside the lower quartile region while those outside the upper 
quartile are considered extreme outliers. Outliers usually only represent a small 
portion of the data and there are many reasons for the appearance of outliers; human 
error or simply through natural deviations in populations. An outlier could also be 
the result of a flaw in the research hypothesis which may warrant further 
investigation.  
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Figure 12 Boxplot - Display of Distribution  
The black line dividing the box represents the median of the data. The lower and 
upper edges of the box are represented by the lower and upper quartiles of the data. 
This means that 50% of the observations fall within the range of the box, while 25% 
fall below and above the lower (Q1) and upper (Q3) quartiles, respectively. The 
whiskers mark those values which are 1.5 x IQR from the upper and lower quartiles. 
The IQR is the inter quartile range: the distance between Q1 and Q3. The outliers are 
defined as any data values that are above or below the threshold; Q3 + 1.5 x IQR and 
Q1 – 1.5 x IQR  
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Boxplots are used to display differences between datasets and the distribution of the 
dataset elements without postulating about the underlying statistical distribution, in 
other words they are non-parametric. The layout of the data helps show asymmetry 
in the distribution of the data, as well as to identify outliers. The programme 
language R was used to generate boxplots and density plots by inputting the data into 
scripts. Analysis of the figures was used to answer the following questions: 
(1) Are there any major differences in the characteristics of disease-associated 
genes compared to the control set? 
(2) Are there any considerable differences in the characteristics of genes 
containing internal hotspots compared to genes with no internal hotspot? 
(3) Is there a variation in the occurrence of recombination hotspots and frequency 
of recombination in disease-associated genes when compared to genes in the 
control set? 
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2.5.  Software 
Python was used extensively to generate and analyze data for this study (URL 
http://www.python.org, Python version 2.7.2). It is an open source, general-purpose, 
programming language used by Scientists for most kinds of software development. It 
was first released in 1991 and comes with extensive standard libraries and is very 
user friendly. It may be used in conjunction with other programming languages but is 
mostly used as a scripting language (Shaw, 2012). 
The other programming language and software environment used extensively for this 
study, R, is also an open source language used for both developing statistical 
software and data analysis (URL http://cran.r-project.org/mirrors.html, R version 
2.13.1). I use R for the purpose of generating all the boxplot and density plots. 
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CHAPTER THREE 
Results 
 
The disease-associated gene dataset used for this section of the study was extracted 
from the OMIM database and the control dataset from the Ensembl database. The 
disease-associated gene set included a total of 13095 genes while the control set 
totaled 38256 genes. The first sets of figures (Figures 13 – 16), generated using an R 
script, were designed to compare disease-associated genes and the control set. The 
second sets of figures (Figure 17 – 20) were designed to compare genes that contain 
an internal hotspot to those genes with no internal hotspots, also using an R script. 
The intention of the final sets of figures (Figures 21 – 24) was to determine whether 
the position and frequency of recombination of a hotspot could impact on the 
likelihood of a gene to underlie disease. Each set of figures consists of both a boxplot 
as well as a density plot. The two plots are two different ways to represent the same 
data. In any data analysis a visual representation of the data is the best way to 
illustrate the results and helps with the final interpretation of these results. 
A total of 12 boxplot figures were analysed to answer the following questions: 
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3.1.  Are there any major differences in the characteristics of disease-
associated genes compared to the genes in the control set? 
3.1.1. Analysis of the Base Composition: GC content 
In the dataset of 13095 disease-associated genes, the average GC content per gene is 
46.83%, while in the control set of 38256, the average GC content per gene is 
45.60%.  
The two plots, shown in Figure 13, represent the percentage distribution of GC 
content in disease-associated genes compared to genes in the control set. A review of 
the plots seems to confirm only a very minor difference in percentage distribution of 
GC content and in fact when comparing the mean and median values of both datasets 
the difference is negligible. The density plot shows an estimate of the actual densities 
and represents a different view of the same data shown by the boxplot. In this case, it 
also shows that there clearly is no substantial difference in the percentage 
distribution of GC content in disease-associated genes compared to genes in the 
control set. It may, however, be important to note the number of outliers that are 
visible in both the disease-associated gene and non-disease gene data. These outliers 
outside the upper quartile and are therefore considered extreme outliers. Since they 
differ substantially from the rest of the data, they may prove to be worthy of further 
investigation. 
 
 
 
n=13095 
 
 
 
 
 61 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 Percentage GC content in disease-associated genes compared to 
genes in the control set  
This boxplot figure, and its associated density plot, illustrates the percentage GC 
content in disease-associated genes compared to the control set. It shows that there is 
a negligible difference between the two sets. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.1.2. Analysis of the Genetic Variation: SNP count  
In the dataset of 13095 disease-associated genes, the average SNP count is 1089.52 
per gene (including both exonic and intronic regions), while the average SNP density 
is 1.59 SNPs per 10kb. Conversely, in the control set of 38256 genes, the average 
SNP count is 251.67 per gene (including both exonic and intronic regions), while the 
average SNP density is 1.62 SNPs per 10kb.  
The two plots, shown in Figure 14, represent the SNP density per 10kb in disease-
associated genes compared to genes in the control set. A review of the plots validates 
that there is no considerable difference in SNP density per 10kb between disease-
associated genes and genes in the control set with little difference in the mean and 
median values of both datasets. The density plot reiterates this finding. It may, 
however, again be important to note the substantial number of outliers visible in both 
the disease-associated gene and non-disease gene data. These outliers outside the 
upper quartile and are therefore considered extreme outliers. Since they differ 
substantially from the rest of the data, they may prove to be worthy of further 
investigation. 
 
 
 
 
 
n=13095 
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Figure 14 SNP density in disease-associated genes compared to genes in the 
control set 
This boxplot figure, and its associated density plot, illustrates the difference in SNP 
density in disease-associated genes compared to genes in the control set. It shows a 
very little difference in SNPs per 10kb between the two sets. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.1.3. Analysis of Gene Length 
In the dataset of 13095 disease-associated genes, the average length of a gene is 
75518bp. The largest gene, transmembrane protease, serine 3 (TMPRSS3), is 
5379013bp and the shortest gene, Phosphatidylinositol N-
acetylglucosaminyltransferase subunit Y (RP11-466G12.4.1), is 216bp. Conversely, 
in the control set of 38256, genes, the average length is 17402bp. The largest gene, 
ATP/GTP binding protein-like 4 (AGBL4), is 1491058bp and the shortest gene, T 
cell receptor delta diversity 1 (TRDD1), is 7bp. 
The two plots, illustrated in Figure 15, show the distribution of gene length in 
disease-associated genes compared to genes in the control set. A review of these 
plots indicates that there is a difference in distribution, with disease-associated genes 
showing a greater tendency to be longer than genes in the control set. The density 
plot shows a different view of the same data and it is clear that disease-associated 
genes are generally longer than genes in the control set.  
The outliers, for this data, are concentrated towards the higher end of the scale 
indicating that it is the much longer genes in both groups that may, in reality, be the 
cause of this result as they are considerably different from the remaining data. These 
data points lie outside the upper quartile and are therefore considered extreme 
outliers. Since they differ substantially from the rest of the data, they may prove to be 
worthy of further investigation.  
 
 
n=13095 
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Figure 15 Length of disease-associated genes compared to genes in the 
control set  
This boxplot figure, and its associated density plot, illustrates the difference in gene 
length of disease-associated compared the genes in the control set. It shows that 
disease-associated genes are longer in length than the genes in the control set. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.1.4. Analysis of the Position Effect: Distance from chromosome end 
In the dataset of 13095 disease-associated genes, 4443 genes were closer to the 
chromosome start while 8652 genes were closer to the chromosome end. In the 
control set of 38256 genes, 12423 genes were closer to the chromosome start, while 
25833 genes were closer to the chromosome end.  
The two plots, illustrated in Figure 16, show the distribution of both disease-
associated genes and genes in the control set within the chromosome length. A 
review of these plots confirms that there seems to be only a slight difference in the 
distribution, with neither disease-associated genes nor the genes in the control set 
showing any trend for occurring nearer to the chromosome ends. The density plot 
validates these findings with a clear indication that neither disease-associated genes 
nor genes in the control set tend to lie closer to the chromosome ends.   
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Figure 16 Position of genes on chromosome  
This boxplot figure, and its associated density plot, illustrates the position of disease-
associated genes from the chromosome ends compared the position of the genes in 
the control set from the chromosome ends. It shows that position of the gene on the 
chromosome has little effect on disease-gene status. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.2 Are there considerable differences in the characteristics of genes 
containing internal hotspots compared to genes with no internal hotspots? 
By further categorising the disease-associated gene and list of genes in the control set 
into a subset of genes that; (1) contain an internal hotspot and (2) do not contain an 
internal hotspot, additional analysis determined whether the presence of the hotspot 
within the gene differed between disease-associated genes and genes in the control 
set. 
3.2.1. Analysis of the Base Composition: GC content 
From the datasets of 13095 disease-associated genes and 38256 genes in the control 
set (a total of 51351 genes), 34850 genes contained internal hotspots while 16501 
contained no internal hotspots. The genes with an internal hotspot had an average GC 
content of 45.62% per gene while the genes with no internal hotspot had an average 
GC content of 46.52%.  
The two plots, shown in Figure 17, illustrate the percentage distribution of GC 
content of genes that contain an internal hotspot compared to those that have no 
hotspot. A review of the plots confirms that there is no substantial difference in 
percentage distribution of GC content here either and in fact when comparing the 
mean and median values of both dataset the difference is again very small. The 
density plot illustrates that there is no substantial difference in the percentage 
distribution of GC content in genes that contain an internal hotspot compared to 
genes that do not contain a hotspot. 
 
 
 
 
 
 69 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Percentage GC content in genes with an internal hotspot 
compared to genes with no internal hotspot  
This boxplot figure, and its associated density plot, illustrates the percentage GC 
content in genes that contain an internal hotspot compared to genes that do not 
contain an internal hotspot. It shows a negligible difference between the two sets. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.2.2. Analysis of Genetic Variation: SNP count 
From the datasets of 13095 disease-associated genes and 38256 genes in the control 
set (a total of 51351 genes), 34850 genes contained internal hotspots while 16501 
contained no internal hotspots. The genes with an internal hotspot had an average 
SNP density of 1.633 per 10kb while the genes with no internal hotspot had an 
average SNP density of 1.5738 per 10kb. 
The two plots, shown in Figure 18, illustrate the SNP density of genes that contain an 
internal hotspot compared to those that have no hotspot. A review of the plots seems 
to confirm that there is no substantial difference in the SNP density here either and in 
fact when comparing the mean and median values of both dataset the difference is 
again very small and the density plot reaffirms this finding. 
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Figure 18 SNP density in genes that contain an internal hotspot compared to 
genes that do not contain an internal hotspot  
This boxplot figure, and its associated density plot, illustrates the SNP density of 
genes that contain an internal hotspot compared to genes that do not contain an 
internal hotspot. It shows that there is very little difference between the two sets. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.2.3. Analysis of Gene Length 
From the datasets of 13095 disease-associated genes and 38256 genes in the control 
set (a total of 51351 genes), 34850 genes contained internal hotspots while 16501 did 
not contain an internal hotspot. The average length of a gene with an internal hotspot 
is 46663bp compared to the average length of a gene with no internal hotspot, 
1722bp.  
The two plots, illustrated by Figure 19, show the distribution of gene lengths in genes 
with an internal hotspot compared to genes with no internal hotspot. A review of 
these plots indicates that there is indeed a difference in distribution, with genes 
containing a hotspot showing a greater tendency to be longer than genes with no 
internal hotspot. The density plot shows an estimate of the actual densities and also 
clearly shows that genes containing an internal hotspot are longer than genes with no 
internal hotspot.  
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Figure 19 Length of genes that contain an internal hotspot compared to 
genes that do not contain an internal hotspot  
This boxplot figure, and its associated density plot, illustrates the difference in length 
of genes that contain an internal hotspot compared to genes that do not contain an 
internal hotspot. It shows  
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles. 
 
 
 
 
 74 
 
3.2.4. Analysis of Position Effect: Distance from chromosome end 
From the datasets of 13095 disease-associated genes and 38256 genes in the control 
set (a total of 51351 genes), 34850 genes contained internal hotspots while 16501 
contained no internal hotspots. As mentioned in the previous section, in the dataset of 
13095 disease-associated genes 4443 genes were closer to the chromosome start 
while 8652 genes where closer to the chromosome end. In the control set of 38256 
genes, 12423 genes were closer to the chromosome start, while 25833 genes were 
closer to the chromosome end.  
The two plots, illustrated in Figure 20, show the distribution within the chromosome 
length of genes with an internal hotspot and genes with no internal hotspot. A review 
of these plots, as well as the Figure 14 in Chapter 1, confirms that there seems to be 
only a slight difference in the distribution, with neither genes that contain a hotspot 
nor genes that do not showing any trend for occurring near the chromosome ends. 
The density plot also gives an indication that neither genes with a hotspot nor genes 
with no hotspot tend to lie close to the chromosome ends.   
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Figure 20 Position of genes on chromosome  
This boxplot figure, and its associated density plot, illustrates the position from the 
chromosome ends of genes that contain an internal hotspot compared the position 
from chromosome ends of the genes with no internal hotspot. It shows that position 
of the gene on the chromosome has little effect on whether a gene contains an 
internal hotspot or not. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 
percentile, or the interquartile range (IQR). The horizontal line in the box shows the 
median value while the asterisks (*) shows the mean value. The outliers (1.5 x IQR) 
are shown as circles.  
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3.3. Is there variation in the frequency of recombination in the hotspots of 
disease-associated genes compared to the frequency of recombination in the 
hotspots of the genes in the control set? 
3.3.1. Analysis of the occurrence of recombination hotspots in disease-
associated genes compared to recombination hotspots of the genes in the 
control set 
There were 13095 disease-associated genes of which 12488 (95.37%) contained 
hotspots and there were 38256 genes in the control set of which 22362 (58.45%) 
contained hotspots.  
These results, shown in Figure 21, indicate that not only are disease-associated genes 
longer, as seen in the previous two sections, but that disease-associated genes are 
also highly likely to contain a hotspot. 
 
 
 
 
 77 
 
 
 
 
 
 
 
 
 
Figure 21 Comparison of hotspot position in disease-associated genes versus hotspot position of the genes in the control set 
A bar chart representing the distribution of recombination hotspots within disease-associated genes and the genes in the control set. It 
shows that disease-associated genes are longer than the genes in the control set and also contain more internal hotspots. 
 
   Disease-associated genes                       Control Set 
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3.3.2. Analysis of the frequency of recombination in the hotspots of disease-
associated genes compared to the frequency of recombination in the hotspots of 
the genes in the control set 
A visual inspection of the boxplot in Figure 22 reveals that the distribution of the 
frequency of recombination in disease-associated genes that contain an internal 
hotspot compared with the genes in the control set that contain an internal hotspot is 
slightly higher in disease-associated genes (mean value of 9.937) than genes in the 
control set (mean value of 5.882). The distribution for both datasets is skewed to the 
left with the bottom whisker much longer than the top whisker. From this boxplot we 
may determine that there is slightly higher frequencies of recombination in disease-
associated genes that contain an internal hotspot than in genes in the control set that 
contain an internal hotspot. 
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Figure 22 Frequency of recombination of internal hotspots of disease genes 
compared to the frequency of recombination of internal hotspots of genes in the 
control set  
This boxplot figure, and its associated density plot, illustrates the frequency of 
recombination of internal hotspots of disease genes compared to the internal hotspots 
of genes in the control set. It shows that there is somewhat more recombination in the 
hotspots of disease-associated genes.  
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3.3.3. Analysis of the frequency of recombination of the highest scoring 
hotspot for each disease-associated gene compared to the frequency of 
recombination of the highest scoring hotspot of each gene in the control set. 
A visual assessment of the boxplot in Figure 23 reveals that the distribution of the 
frequency of recombination of the highest scoring hotspot for each disease-
associated gene compared to the frequency of recombination of the highest scoring 
hotspot for each gene in the control set is, again, fairly similar with a mean value of 
20.021 and 18.009 respectively. The distribution for both datasets is skewed to the 
left with the bottom whisker much longer than the top whisker. This difference is 
more prevalent in the frequency of recombination in the highest scoring hotspot that 
lies closest to genes in the control set. From this boxplot we may determine that there 
is an inconsequential difference between the frequencies of recombination in the 
highest scoring hotspot closest to genes in the control set than in the hotspots closest 
to disease-associated genes. There is however, more variance in the frequency of 
recombination in the highest scoring hotspot closest to genes in the control set but 
this may only be due to the difference in population size. 
 
 
 
 
 
 
 
 
 
 81 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23 Frequency of recombination of the highest scoring hotspot for 
each disease-associated gene compared to the highest scoring hotspot for each 
gene in the control set  
This boxplot figure, and its associated density plot, illustrates the frequency of 
recombination of the highest scoring hotspot for each disease-associated gene 
compared to the frequency of recombination for the highest scoring hotspot for each 
gene in the control set. It shows that there is a slight increase in recombination of the 
highest scoring hotspot for each disease-associated gene. 
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3.3.4. Analysis of the frequency, distance and overall scoring metric of 
hotspots nearest to disease-associated genes compared to the frequency, 
distance and overall scoring metric of hotspots nearest to the genes in the 
control set. 
It is important fact to mention here is that the scoring system was developed because 
I had not anticipated such a high percentage of genes would contain a hotspot. The 
scoring system, however, was only used to analyze a small subset of disease-
associated genes and genes in the control set that did not contain an internal hotspot 
but rather lie near a hotspot. This was because the score metric was not relevant to 
genes that did contain an internal hotspot because “distance from hotspot” was not a 
factor.  
Once each gene in the human genome had a score assigned to it, the overall 
difference in scoring of genes in the disease-associated gene was compared to the 
overall scoring of genes in the control set.  
A visual assessment of the boxplot in Figure 24 reveals that the distribution of the 
score metric of those hotspots that lie closest to disease-associated genes with no 
internal hotspot compared to the score metric of those hotspots that lie closest to 
genes in the control set that have no internal hotspot is, again, fairly similar with a 
mean of 0.0185 and 0.0124 respectively. The distribution for both datasets is skewed 
to the right with a number of visible outliers. From this boxplot we may determine 
that there is only a slight difference in the dataset, with the maximum scores of the 
hotspots that lie closest to genes in the control set slightly higher than the maximum 
scores of the hotspots closest to disease-associated genes.  
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Figure 24 Score Metric of disease-associated genes compared to the score 
metric of genes in the control set  
This boxplot figure, and its associated density plot, illustrates the score metric of 
disease genes compared to the score metric of the genes in the control set. It shows 
there is little difference between the disease-associated genes when compared to the 
genes in the control set when one looks at the subset of genes that do not contain an 
internal hotspot but rather lie near to a hotspot.  
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CHAPTER FOUR 
Discussion and Conclusion 
 
In this thesis, I have reviewed a set of features that represent general properties of 
human genes. The control set of genes, assembled using the ~38 000 known genes, 
pseudogenes and RNA genes from Ensembl, and which have no known association 
with any human disease, were evaluated against the ~13 000 disease-associated 
genes listed in Online Mendelian Inheritance in Man (OMIM).  
Other researchers have examined these same features independently in various 
studies but, to my knowledge, there have been no comprehensive studies 
investigating all the features examined in this study. The data presented in this thesis 
collates analysis of all known disease-associated genes as well as all known human 
genes that have not thus far been identified as being involved in disease.   
Table 4 gives a comparison of mean values and standard deviations for the various 
features of 13095 disease-associated genes and 38256 genes in the control set. The 
data clearly shows that disease-associated genes are longer than genes in the control 
set, while base composition (GC content), position on the chromosome and genetic 
variation (SNPs) do not differ significantly between disease-associated and genes in 
the control set.  
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The finding that disease-associated genes are longer than genes in the control set is 
not novel and moreover it is consistent with what has previously been described in 
literature.
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Table 4 Tabulated displays of the mean and measure of standard deviation (S.D) for the reviewed features of the 13095 
disease genes and 38256 non-disease genes.  
 Disease-associated 
genes 
 Control set   Unit  
 Mean S.D Mean S.D  
GC content  46.83 8.02 45.60 7.91 % 
SNP density  1.60 1.40 1.62 1.97  SNPs per 10kb  
Gene length  75518 1522173 17402 5574779  bp   
Position on chromosome       
Nearest hotspot  34745196 26813339 37630704 27392564  bp   
Number of hotspots       
Internal hotspots  95.36  58.45   %  
Nearest hotspot  4.64  41.55   %  
Frequency of recombination       
All hotspots  10.40 17.20 10.88 18.38  cM/Mb  
Internal hotspots  9.94 16.60 5.88 12.50  cM/Mb  
Nearest hotspot  20.02 24.20 18.01 22.55  cM/Mb  
Score        
Nearest hotspot  0.0185 0.21 0.0124 0.12  
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It can be reasoned that this is due to the fact that the longer the gene is, the more likely it is 
to undergo a disease-causing mutation based purely on the increased length of gene 
available to undergo random mutations. In this study I was able to confirm these results 
with an average disease-associated gene length of 75kb compared to the average gene 
length of 17kb in the control set of genes.  
The plot in Figure 15 shows, that even at the long end of the scale, disease-associated 
genes are generally longer. The plot in Figure 19 clearly shows that disease-associated 
genes are more likely to contain an internal hotspot than genes in the control set.  
It is important to note, however, that even though the gene length results support previous 
findings; it might be a result of the fact that the control gene list used in this study has not 
been curated and contains a substantial amount of smaller genes compared to the well-
curated disease-associated gene list from OMIM. Given that disease-associated genes are 
longer than genes in the control set it could be purely by chance alone that disease-
associated gene are more likely to contain a hotspot, in other words the increase in hotspot 
frequency may be a result of longer gene length.  
Question: if a disease-associated gene contains a hotspot is this purely due to the fact that it 
is longer, in other words the hotspot does not contribute to disease gene status, or is it 
because the hotspot is contributing to the likelihood of being a disease-associated gene?  
If one compares the length of genes containing a hotspot compared to the length of genes 
not containing a hotspot there is definitely a negative correlation (Figure 25). 
 
 
 
 
 88 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 Relationship between gene length and the presence or absence of recombination hotspots  
This figure illustrates the relationship between disease-associated genes and the genes in the control set and the likelihood that they will 
contain an internal hotspot. It shows that the presence of a hotspot is not sufficient on its own to cause disease gene status. 
The box represents the data distribution between the 25
th
 percentile and the 75
th
 percentile, or the interquartile range (IQR). The horizontal 
line in the box shows the median value. The outliers (1.5 x IQR) are shown as circles. 
Disease (hotspot) Disease (no hotspot)    Control set (hotspot) Control set (no hotspot) 
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Disease genes that contain a hotspot are longer than genes in the control set that contain a 
hotspot but disease-associated genes that do not contain a hotspot are also longer than 
genes in the control set that do not contain a hotspot and this result gives some indication 
that the presence of a hotspot is not sufficient on its own to cause disease gene status. 
One could speculate that the number of extreme outliers could be a consequence of the 
varying distance that a recombination hotspot lies from a gene. The distance that the 
hotspot lies from the gene and the size of the gene could both play a role in the fact that 
there are so many extreme outliers, especially in the genes in the control set where the 
genes are smaller in size.   
When one assesses the middle of the range dataset, in other words, only the disease-
associated gene and non-disease gene lengths between 2000bp and 1500000bp, and 
excluding the smallest genes, this observation changes, as shown in Figure 26. The 
percentage of disease-associated genes with a hotspot increases to 97.02% while the 
percentage of genes in the control set with a hotspot increases to 91.12%. This 
demonstrates that the presence of a hotspot in a gene is a consequence of gene length rather 
than a feature that establishes gene status.  
This result could be due to many factors, the most obvious being that the large numbers of 
very short genes, which are possibly genes which have not as yet been reported as having a 
function in disease, could be a consequence of poor annotations or pseudogenes; however 
future research would need to be done to elucidate this possibility.
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Figure 26 Comparison of the median gene lengths of disease-associated genes and genes in the control set  
A graphical representation of the distribution of recombination hotspots within disease-associated genes and genes in the control set using a 
subset of the total genes, i.e. the middle of the range dataset excluding the smallest genes. This demonstrates that the presence of a hotspot 
in a gene is a consequence of gene length rather than a feature that establishes gene status. 
n = 12587 n = 15807 
 
  Disease-associated genes                                                                 Control Set 
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The observation that a higher proportion of disease-associated genes contain hotspots when 
compared to the proportion of genes in the control set that contain hotspots is a novel 
finding, while the other results are not entirely consistent with the findings that have been 
previously published Reference. The reason for these discrepancies may be because no 
study has systematically evaluated gene length, base composition (GC content), positional 
effect (shortest distance to chromosome end) and genetic variation (SNP density) of all 
known genes from Ensembl (coding and non-coding genes, psuedogenes, RNA gene etc.) 
as well as all the known disease-associated genes in OMIM in a single study.  
This study also makes special reference to the relationship between recombination hotspots 
and their presumed function in disease-associated genes. Most other studies make use of a 
randomly selected subset of genes from Ensembl, as well as other data sources, as a 
representative model, with statistical analysis to extrapolate their findings.  
It may be interesting to note that the GC content in genes is different compared to the GC 
content of the whole genome. In genes, the average GC content is between 45% and 50%, 
and is evenly distributed. In the genome, however the GC content is ~41% GC with an 
uneven distribution skewed to the left. As a consequence, regions of high GC content (62-
68%) have higher relative gene density than regions of lower GC content (Lander et al., 
2001, International Human Genome Sequencing Consortium, 2001).  
If one refers to the data in Table 4, the results show that the study found no substantial 
differences between the percentages GC content in disease-associated genes when 
compared to genes in the control set. These findings may be a result of the larger control 
set and consequently the emergence of more outliers or simply the fact that there are many 
more genes in the dataset. This study also concludes that there is no substantial difference 
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between the percentage GC content in genes that contain an internal hotspot and genes that 
do not contain an internal hotspot suggesting that GC content does not influence where 
recombination hotspots occur. This is in contradiction to what has been published in 
previous literature as, to my knowledge, no previous literature has been published 
specifically on the GC content of coding regions of disease-associated genes and genes in 
the control set. However, there have been publications that support a causal relationship 
between GC-content and recombination rate in humans as well as identifying that 
recombination hotspots are associated with local increases in GC content (Fullerton et al., 
2001, Freudenberg et al., 2009). It has been proposed that this effect might result from 
biased gene conversion (BGC). In this process gene conversion, in other words, the 
copy/pasting of one allele onto the other heterozygous loci during meiotic recombination, 
is biased towards GC-alleles, and leads to an increased probability of GC-rich regions 
compared to AT-rich regions (Duret et al., 2008). This BGC should render enrichment of 
GC-content in regions of high recombination compared to regions of low recombination. 
The findings about SNP density in disease-associated genes compared to genes in the 
control set was not expected. Previous publications have confirmed the average SNP 
density as 8.33 SNPs per 10kb in the human genome and this study showed the average 
SNP density as 1.61 SNPs per 10kb within genes. The difference in these findings are due 
to the fact that the whole genome will have a higher SNP density because intergenic 
regions, in other words “non-gene DNA”, can tolerate changes much more than coding or 
gene regions and therefore there will be many more SNPs outside of gene regions. Also, 
since it is known that disease-associated genes are generally longer than genes in the 
control set logically they should have more SNPs. These results show that whilst total SNP 
count per gene is higher in disease-associated genes according to their length, there is no 
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large variation in SNP density in disease-associated genes compared to genes in the control 
set. While attempting to identify genome-wide genes likely to be involved in human 
genetic diseases Lopez-Bigas et al concluded that genes involved in disease tend to be 
situated in conserved regions of the genome exposed to strong evolutionary constraints and 
that these genes therefore had not had the opportunity to accumulate many variations 
(Lopez-Bigas et al., 2004). This finding is supported by earlier studies that have 
hypothesised that the most severe “disease” genes are human essential genes, or 
housekeeping genes, and any disruption to their function will cause fatal consequences. It 
is thus proposed that these genes are less likely to tolerate sequence changes and therefore 
will contain fewer polymorphisms (Tu et al., 2006). These findings are however, not 
supported in this study and this may be because of the SNP data used. At any point in time, 
SNP records are certainly unlikely to catalogue all known SNPs. The current data for 
human variome is continuously and rapidly expanding as many more genomes from 
diverse ethnic origins, especially in Africa, are sequenced. For this study, SNP data from 
Ensembl SNPMart 65 was used. While this database is comparatively current, SNP density 
will continue to be limited by our limited knowledge for some time yet and a real 
conclusion about SNP density in disease-associated genes and the control set cannot be 
conclusively drawn. 
Disease-associated genes appear randomly distributed across the genome, which 
corresponds with the random distribution of all genes across the genome. Similarly, when 
examining the distribution of recombination hotspots and their frequencies, a random 
distribution in seen across the genome. This relationship is illustrated in Figure 27. It 
shows where the genes lie on the chromosome as well as the distribution of hotspots and 
their frequency of recombination and that these are random distributions and not skewed 
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towards the centers or ends of the chromosome. The analysis of the distance of a gene to 
the chromosome end corroborates this finding that recombination is not facilitated more 
easily near the chromosome ends as would be suggested by the hypothesis that the integrity 
of a chromosomes tertiary structure is more flexible towards chromosome ends. This may 
be due to the telomere, a region of repetitive nucleotide sequences at the end of a 
chromosome. The telomere protects the end of the chromosome from deterioration or from 
fusion with neighboring chromosomes by maintaining a well-packed tertiary structure. 
Telomere regions deter the degradation of genes near the ends of chromosomes by 
allowing chromosome ends to shorten, which necessarily occurs during chromosome 
replication (Nachman, 2002, Maddar et al., 2001).  
On initial observation of Figure 27, it appears that on some chromosomes, gene dense 
regions seem to undergo fewer recombination events, for example on chromosome 3 at 
p21.31 and chromosome 16 at q22.1 and q22.2, and this could warrant further investigation 
in future studies.  
To summarize, this study has determined that even though disease-associated genes are 
longer than genes in the control set and more likely to contain an internal recombination 
hotspot this does not indicate that these are traits that cause disease gene status. However, 
the fact that many genes in the control set do in fact contain hotspots, does not rule out the 
possibility that these genes may be found to underlie disease in the future. In general, it is 
difficult to make definitive conclusions about the control set if genes not implicated in 
disease as genes can only be defined as such within the limits of our current knowledge. 
This issue is discussed in Tiffin et al., 2009 (review article). In this study I have observed 
such differences between disease-associated genes and the control set. It is not possible,
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however, to demonstrate a causal relationship between these factors within the current 
study. I propose possible relationships between disease-associated genes and the control set 
and their characteristics, but further work is necessary to test whether causal relationships 
do exist. It is possible that the increase in number of hotspots indicates more variability 
being introduced and therefore more likelihood of causing altered phenotype, including 
disease phenotype. It could also be that containing an internal recombination hotspot 
predisposes a gene to cause disease and that longer genes are more likely to contain a 
hotspot and therefore longer genes are more likely to be disease-associated genes. In order 
to prove either hypothesis, further investigation is required. 
Co-occurring traits in disease-associated genes can contribute as supporting evidence for a 
hypothesis but they do not determine causality. In order to determine causality one could, 
for example, look at different ethnicities where the distribution of hotspots differ to 
established recombinant hotspot sets which are Eurocentric and identifying if the link 
between disease and the occurrence of hotspots still holds true or whether it is in fact only 
gene length that is the defining factor.  
In conclusion, I propose that genes that are longer are more likely to be disease-associated 
genes because they have more SNPs that might have disease-associated alleles and because 
they are more likely to contain a recombination hotspot which leads to greater variation 
and consequently more chance of a disease phenotype arising. 
One should keep in mind that Next Generation Sequencing is aiding in the discovery of 
disease genes by sequencing the entire protein-coding sequence, or exome and this will 
make studies, such as the one done here, even more valuable in the future. 
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Future Direction 
This approach gives us the potential to identify “most likely” disease-associated genes in a 
population-specific manner, and to look at the effect of distance/frequency of 
recombination hotspots on aetiological genes for diseases that have varying prevalence 
between populations. Given that, to date, so much disease-associated gene research is 
conducted within the Northern Hemisphere in a predominantly Caucasian environment, 
and then translated to the African populations, this would have great implications for 
prediction and analysis of candidate disease-associated genes exclusively for indigenous 
Africans. If we can link population structure to prediction of disease-associated genes, we 
pave the way to disease-associated gene prediction specifically adapted for indigenous 
Africans, with a methodology that is equally applicable to other populations.  
African natives are the most ethnically diverse population in the world (Tishkoff et al., 
2002). This is because the African continent is regarded as the “cradle of mankind” where 
the first human remains were discovered from 200 000 years ago. For this reason 
initiatives like HapMap (URL www.hapmap.org/) and 1000 Genome Project (URL 
http://www.1000genomes.org/) have focused on African-based studies for disease-related 
genetic and genomic research. To date, the complete genomes of two individuals as well as 
the exome sequence of three individuals from indigenous populations in Southern Africa 
have been sequenced (Schuster et al., 2010). The 1000 Genome project has samples from 
~500 DNA samples from West African Ancestry while HapMap is working with ~480 
from East and West Africa. The problem is that even though there is a significant amount 
of data becoming available about African genomes, there is not a lot of information about 
genes that cause disease in Africans as well as disease prevalence in African populations. 
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Recent genetic studies on African Americans have uncovered similar methods to creating 
detailed genome maps of African American DNA and this new technique will enable 
Scientists to locate the genes that cause disease (Hinch et al., 2011). As information 
becomes known about the genetics of African diseases, it may become easier to test 
whether the increased frequency of recombination hotspots in Africans results in different 
disease-associated genes in these populations. This will, however, also require the 
assembly of reliable test sets of African-specific disease-associated genes and the 
associated control sets of non disease-associated genes. 
Additional studies surrounding known translocation breakpoints that have been identified 
in cancers could also prove an interesting avenue for further computational analysis of 
sequences. The methods used in a recent study on translocations in lymphomas and 
leukemias in humans (Hakim et al., 2012) may potentially assist with identifying other 
motifs or sequence characteristics responsible for the predisposition to translocations in 
other forms of cancer.  
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Appendix 1 
cleanup_hotspot_data.py  
This program reads through (hotspotdata.txt) file. This program was designed to extract 
the chromosome name, hotspot co-ordinates and frequency of recombination data and 
write these results into a tab delimited output file (File 2 – hotspots_data_clean.txt). 
# open file and read lines into list 
directory = "C:/Students/tracey/analysis/" 
hotspots_infile = open(directory + hotspots_filename) 
hotspots_lines = hotspots_infile.readlines() 
outfile = file(directory + 'hotspots_data_clean.txt', 'a') 
# for each line, split into list at tabs 
x = 0 
print 'there are', len(hotspots_lines), 'lines in the file' 
for hotspot_line in hotspots_lines: 
# print hotspot_line 
    line_list = hotspot_line.split('\t') 
    if len(line_list) == 4 and  line_list[0].startswith('chr'): 
        print>>outfile, hotspot_line.strip() 
    else: 
        print 'line', x, 'is an exception' 
#        print hotspot_line 
    x = x+1 
outfile.close()         
_______________________________________________________________________ 
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get_gene_coordinates.py  
This program reads through multiple .ftp files stored in a single working directory and 
extracts the gene co-ordinates. This program was designed to extract the ENSEMBL gene 
ID, gene name, chromosome name, and gene co-ordinates (gene start and gene end) result 
per gene and write these results into two tab delimited output files (File 3 – 
disease_gene_coords.txt and File 4 – nondisease_gene_coords.txt). 
latest_database = "ensembl_mart_65" 
nondisease_outfile = file("nondisease_gene_coords.txt", 'a') 
disease_outfile = file(disease_gene_coords.txt", 'a') 
# END USER INPUTS 
#_______________________________________________________________ 
# collect list of disease gene IDs 
disease_genes_infile = "disease_genes.txt" 
dg_ids = [ ] 
infile = open(disease_genes_infile) 
lines = infile.readlines() 
for line in lines: 
    line = line.split('\t') 
    dg_id = line[0] 
    dg_id = dg_id.strip() 
    if dg_id not in dg_ids: 
        dg_ids.append(dg_id)  
print "there are", len(dg_ids), "IDs in the disease gene ID list" 
# connect to local Ensembl database 
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import MySQLdb as dbi 
dbc = dbi.connect(host="martdb.ensembl.org", 
                  db= latest_database, 
                  user = "anonymous", 
                  port = 5316) 
print 'connected' 
# get all records one at a time. 
x=0 
cursor = dbc.cursor() 
cursor.execute("""select distinct  stable_id_1023, display_label_1074, name_1059, 
seq_region_start_1020, seq_region_end_1020 
                  from  hsapiens_gene_ensembl__gene__main;""")                          
row = cursor.fetchone() 
while row is not None: 
#   print 'row is', row 
    ensembl_id =row[0] 
    ensembl_id.strip() 
    gene_name= row[1] 
    gene_name.strip() 
    chrom_name = row[2] 
    chrom_name.strip() 
    gene_start =row[3] 
    gene_end = row[4] 
    if ensembl_id in dg_ids: 
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    print>>disease_outfile, ensembl_id, '\t', gene_name,'\t', chrom_name,'\t', gene_start,'\t', 
gene_end 
     else: 
print>>nondisease_outfile, ensembl_id, '\t', gene_name,'\t', chrom_name,'\t', 
gene_start,'\t', gene_end 
     row = cursor.fetchone() 
    x=x+1 
    print x 
cursor.close() 
disease_outfile.close() 
nondisease_outfile.close() 
dbc.close() 
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hotspot_vs_gene_script.py  
This program reads through gene filename (disease_gene_coords.txt and 
nondisease_gene_coords.txt) files and hotspots filename (hotspots_data_clean.txt) file. 
This program was designed to extract hotspot co-ordinates per chromosome and create a 
directory for disease-associated genes and genes in the control set. Then the script 
measures the distance and frequency of recombination for each gene/hotspot combination 
on each of the chromosomes for the disease-associated gene list and non-disease gene list. 
The program then selects the top scoring hotspot data for each gene and writes these 
results into two tab delimited output files (File 5 – score_output_disease_gene_coords.txt 
and File 6 – score_output_nondisease_gene_coords.txt). 
from __future__ import division 
# define source files 
x = 0 
gene_filename =['nondisease_gene_coords.txt', 'disease_gene_coords.txt'] # 
hotspots_filename = "hotspots_data_clean.txt" 
chromosomes = ["1", "2", "3", "4", "5", "6", "7", "8","9","10","11","12", "13", 
               "14", "15", "16", "17", "18", "19", "20","21" ,"22", "X"] 
hotspots = {} 
for chromosome in chromosomes: 
    hotspots[chromosome] = [] 
print hotspots 
# Get hotspot coordinates and create dictionary 
# open file and read lines into list 
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hotspots_infile = open(directory + hotspots_filename) 
hotspots_lines = hotspots_infile.readlines() 
# for each line, split into list at tabs 
x = 0 
print 'there are', len(hotspots_lines), 'lines in the file' 
for hotspot_line in hotspots_lines[27:]: 
    x = x+1 
    hotspot_line = hotspot_line.split('\t') 
    chrom = hotspot_line[0] 
    chrom = chrom.strip('chr') 
    chrom = chrom.strip() 
    hp_position = hotspot_line[1] 
    hp_rate = hotspot_line[2] 
    if chrom in chromosomes: 
        hotspots[chrom].append((hp_position,hp_rate)) 
for gene_file in gene_filename: 
    print 'gene_file is', gene_file 
    genes = {} 
# Get gene coordinates and create dictionary 
    gene_infile = open(directory + gene_file) 
    score_outfile = file(directory + "score_output_" + gene_file, 'a') 
    print>>score_outfile, 
"gene_ensembl_id\tmax_score\thp_position\thp_frequency\tdistance\tgene_chrom\tgene_n
ame\tgene_start\tgene_end" 
    gene_lines = gene_infile.readlines() 
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    for gene_line in gene_lines: 
        gene_line = gene_line.split('\t') 
        gene_ensembl_id = gene_line[0] 
        gene_ensembl_id = gene_ensembl_id.strip() 
        gene_name = gene_line[1] 
        gene_name = gene_name.strip() 
        gene_chrom = gene_line[2] 
        gene_chrom = gene_chrom.strip() 
        gene_start = int(gene_line[3]) 
        gene_end = int(gene_line[4]) 
        if gene_chrom in chromosomes: 
            hotspot_list = hotspots[gene_chrom] 
            scores = {} 
            for item in hotspot_list: 
                hp_position = int(item[0]) 
                hp_frequency = float(item[1]) 
                if hp_position < gene_start: 
                    distance = gene_start - hp_position 
                if hp_position > gene_end: 
                    distance = hp_position - gene_end 
                if hp_position > gene_start and hp_position <gene_end: 
                    distance = 0.1 
                hotspot_gene_score = float(hp_frequency/distance) 
                scores[hotspot_gene_score] = (hp_position, hp_frequency, distance) 
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            max_score = max(scores) 
            values = scores[max_score] 
#            print gene_name, gene_chrom, gene_start, max_score, values 
            hp_position = values[0] 
            hp_frequency = values[1] 
            distance = values[2] 
print>>score_outfile, gene_ensembl_id,'\t', max_score,'\t', 
hp_position,'\t',hp_frequency,'\t',distance,'\t', gene_chrom, '\t', gene_name, '\t', 
gene_start, '\t', gene_end 
    score_outfile.close()           
__________________________________________________________________        
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get_all_snp_info.py  
This program reads through multiple .ftp files stored in a single working directory and 
downloads the SNP co-ordinates and chromosome name. This program was designed to 
extract the SNP ID, chromosome name, and SNP position result per gene and write these 
results into separate tab delimited output files (snp_coords_(chrom_x).txt). 
latest_database = "snp_mart_65" 
# END USER INPUTS 
#________________________________________________________________ 
# connect to local database 
import MySQLdb as dbi 
dbc = dbi.connect(host="martdb.ensembl.org", 
                  db= latest_database, 
                  user = "anonymous", 
                  port = 5316) 
print 'connected' 
# create directory of all data 
chromosomes = ["1", "2", "3", "4", "5", "6", "7", "8","9","10","11","12", "13", 
              "14", "15", "16", "17", "18", "19", "20","21" ,"22", "X", "Y"] 
# get all records one at a time. 
for chrom_x in chromosomes: 
    outfile = file("snp_coords_" + chrom_x + ".txt", "a") 
    x=0 
    print 'chrom', chrom_x 
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    cursor = dbc.cursor() 
    cursor.execute("""select distinct variation_name_2026, name_1059, 
seq_region_start_2026 
                      from  hsapiens_snp__variation_feature__main 
                      where name_1059 = '%s';""" % chrom_x)                          
    row = cursor.fetchone() 
    while row is not None: 
        snp_id = row[0] 
        chrom_name = row[1] 
        snp_pos =row[2] 
        print>>outfile, snp_id, "\t", chrom_name, "\t", snp_pos   
        x =x + 1 
        row = cursor.fetchone() 
    print 'completed for chromosome', chrom_x,"; there are", x, " snps" 
    cursor.close() 
dbc.close() 
outfile.close() 
__________________________________________________________________ 
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split_genes_by_chrom.py  
This program reads through gene filename (disease_gene_coords.txt) and 
(nondisease_gene_coords.txt) files and separates the disease-associated gene and genes in 
the control set by chromosome name and writes these results into separate tab delimited 
output files (filename[disease_gene/nondisease_gene]_gene_chrom.txt). 
disease_genes = [disease_gene_coords.txt", 'disease_genes'] 
nondisease_genes  = [nondisease_gene_coords.txt", 'nondisease_genes'] 
files = [disease_genes, nondisease_genes] 
for filename in files: 
    infile = open(filename[0]) 
    lines = infile.readlines() 
    for line in lines: 
        line = line.strip() 
        linedata = line.split('\t') 
        gene_chrom = linedata[2].strip() 
        outfile = file("filename[1] + "_" + gene_chrom + ".txt", 'a') 
        print>>outfile, line 
        outfile.close() 
________________________________________________________________ 
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get_gene_snp_count.py  
This program reads through gene filenames (disease_gene_coords.txt and 
nondisease_gene_coords.txt) files. This program was designed to extract the ENSEMBL 
gene ID, gene name, chromosome name, gene co-ordinates and SNP count per gene and 
write these results into separate tab delimited output files 
(snp_count_disease_genes_chrom_(x).txt). 
gene_coords_dg = ("disease_genes_", 'disease_genes') 
gene_coords_ndg = ("nondisease_genes_", 'nondisease_genes') 
outfile1 = file("snp_count_disease_genes.txt", 'a') 
print>>outfile1, 
"ensembl_id\tgene_name\tgene_chrom_name\tgene_start\tgene_end\tsnp_count" 
outfile2 = file(snp_count_nondisease_genes.txt", 'a') 
print>>outfile2, 
"ensembl_id\tgene_name\tgene_chrom_name\tgene_start\tgene_end\tsnp_count" 
outfile1.close() 
outfile2.close() 
# END USER INPUTS 
#_________________________________________________________________ 
# create directory of all data 
print "creating directory of all snps" 
chromosomes = ["1", "2", "3", "4", "5", "6", "7", "8","9","10","11","12", "13", 
              "14", "15", "16", "17", "18", "19", "20","21" ,"22", "X", "Y"] 
for chrom in chromosomes: 
    infile_name = "snp_coords_" + chrom + ".txt" 
    print 'chrom is', chrom 
    snp_ids = [] 
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    snp_data = [] 
# get all records one at a time from file 
    infile = open(infile_name) 
    print 'infile open for chrom ', chrom 
    lines = infile.readlines() 
    print 'there are', len(lines), 'lines' 
     for line in lines[:100000]: 
        #print 'line is', line 
        snp_coords = line.split("\t") 
        snp_id = snp_coords[0] 
        snp_id = snp_id.strip() 
        chrom_name = snp_coords[1] 
        chrom_name = chrom_name.strip()     
        snp_pos =snp_coords[2] 
        snp_pos = int(snp_pos) 
        if snp_id not in snp_ids: 
            snp_ids.append(snp_id) 
            snp_data.append((snp_id, snp_pos)) 
    print 'there are', len(snp_ids), 'in snp_ids' 
#_________________________________________________________________ 
# Get gene coordinates and find snps that fall in the coordinate 
    print "Processing gene coordinates" 
    gene_coords = [gene_coords_dg, gene_coords_ndg] 
    for item in gene_coords: 
        outfile = file(snp_count_" + item[1].strip() + ".txt", 'a') 
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        #print>>outfile, 
"ensembl_id\tgene_name\tgene_chrom_name\tgene_start\tgene_end\tsnp_count" 
        for chromosome in chromosomes: 
            infile_genes = open(item[0] + chromosome + '.txt' ) 
            lines_genes = infile_genes.readlines() 
            print 'there are', len(lines_genes),'gene lines' 
            for line_genes in lines_genes: 
               line_genes = line_genes.split("\t") 
               ensembl_id = line_genes[0].strip() 
               gene_name = line_genes[1].strip() 
               gene_chrom_name = line_genes[2].strip() 
               gene_start = line_genes[3].strip() 
               gene_start = int(gene_start) 
               gene_end = line_genes[4].strip() 
               gene_end = int(gene_end) 
                if gene_chrom_name == chrom: 
                    snp_count = 0 
                    for data in snp_data: 
                        snp_pos = int(data[1]) 
                        if snp_pos >= gene_start and snp_pos <= gene_end: 
                            snp_count = snp_count +1 
                            #print data, snp_count 
                    print>>outfile, ensembl_id,"\t", gene_name,"\t",  gene_chrom_name,"\t",  
gene_start,"\t",  gene_end,"\t",  snp_count 
       infile_genes.close()   
        outfile.close() 
       dbc.close() 
 
 
 
 
